WO2020132926A1 - Blood sample analysis method and blood coagulation analyzer - Google Patents

Blood sample analysis method and blood coagulation analyzer Download PDF

Info

Publication number
WO2020132926A1
WO2020132926A1 PCT/CN2018/123800 CN2018123800W WO2020132926A1 WO 2020132926 A1 WO2020132926 A1 WO 2020132926A1 CN 2018123800 W CN2018123800 W CN 2018123800W WO 2020132926 A1 WO2020132926 A1 WO 2020132926A1
Authority
WO
WIPO (PCT)
Prior art keywords
detection
coagulation
optical
test object
magnetic bead
Prior art date
Application number
PCT/CN2018/123800
Other languages
French (fr)
Chinese (zh)
Inventor
郭文恒
章姚辉
闫华文
孙骁
Original Assignee
深圳迈瑞生物医疗电子股份有限公司
北京深迈瑞医疗电子技术研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳迈瑞生物医疗电子股份有限公司, 北京深迈瑞医疗电子技术研究院有限公司 filed Critical 深圳迈瑞生物医疗电子股份有限公司
Priority to CN201880099356.1A priority Critical patent/CN112955742A/en
Priority to PCT/CN2018/123800 priority patent/WO2020132926A1/en
Publication of WO2020132926A1 publication Critical patent/WO2020132926A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor

Definitions

  • the invention relates to a medical device, in particular to a blood sample analysis method and a blood coagulation analyzer.
  • the blood coagulation analyzer is used to measure the content of various components in human blood in clinical medicine and quantify the results of biochemical analysis, providing a reliable digital basis for clinical diagnosis of various diseases in patients.
  • the measurement methods of the existing coagulation analyzer mainly include coagulation method, immunoturbidimetry method and chromogenic substrate method.
  • the coagulation method is to detect the change of a series of physical quantities (light, electricity, mechanical motion, etc.) of plasma under the action of a triggering reagent (also called coagulation activator), and then analyze the data obtained by the computer and convert it into the final result .
  • coagulation method can usually be divided into magnetic bead method and optical method, which are mainly used in prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), thrombin Time (TT) and related coagulation factor and other derivative testing.
  • PT prothrombin time
  • APTT activated partial thromboplastin time
  • FIB fibrinogen
  • TT thrombin Time
  • the magnetic bead method and the optical method are two independent detection methods that are different in detection principle and detection components
  • the current mainstream instrument manufacturers either use the magnetic bead method, such as Stargo, in the choice of the coagulation method implementation method (STAGO) companies, either using optical methods, such as Wolfen (IL) and Sysmex (SYSMEX).
  • the magnetic bead method directly uses the coagulation reaction, and the fibrinogen in the plasma is converted into fibrin, and the viscosity in the plasma is increased.
  • the test result is obtained by detecting the swing amplitude of the magnetic bead in the test cup.
  • the optical method is to use the optical principle to probe the change of the turbidity of the test sample in the test cup. Its advantage is that it can output the optical information curve in the test process, so that it can give more valuable judgments on the results and instrument status compared with the magnetic bead method.
  • the disadvantage of the optical method is that it is easily interfered by the color of the sample itself, so that the correct result cannot be obtained or the result cannot be output.
  • the horizontal axis is the wavelength (unit nm)
  • the vertical axis is the absorbance
  • the wavelength has different absorbances, reflecting that the three interferences have different absorption capabilities for light of different wavelengths, especially chyle, which has absorbance in the visible range of 340nm-790nm, which means that when the object contains When there is a large amount of chyle, irradiating the test object with visible light will absorb a large amount of light by the chyle, which will affect the results of the optical method for blood coagulation detection.
  • the invention mainly provides a blood sample analysis method and a blood coagulation analyzer.
  • the blood sample analysis method based on the blood coagulation analyzer first determines whether the sample has interference, and determines whether to use the optical method or the magnetic bead method according to the judgment result Coagulation test, which solves the problem of inaccurate optical detection or inability to output test results due to interference.
  • an embodiment provides a blood sample analysis method, including:
  • the test object contains at least the plasma of the blood sample
  • the processor controls the optical method detection device to perform the coagulation test on the test object based on the optical method;
  • the processor controls the magnetic bead method detection device to perform the coagulation detection on the test object based on the magnetic bead method.
  • an embodiment provides a blood sample analysis method based on a coagulation analyzer, including:
  • Interfering substances refer to substances that have an influence on the coagulation detection based on optical method
  • the interference information it is determined whether the blood sample to be tested is coagulated based on the optical method or the magnetic bead method.
  • an embodiment provides a coagulation analyzer including a pre-judgment device, an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
  • the pre-judgment device is used to perform optical detection on the test object before performing the coagulation test under the control of the processor to obtain an optical detection result.
  • the test object contains at least the plasma of the blood sample;
  • the optical method detection device is used to perform coagulation detection on the measured object based on the optical method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
  • the magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
  • the analyte transfer mechanism is used to transfer the reaction container containing the analyte to a preset position under the control of the processor;
  • the processor is used to determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device performs coagulation detection on the test object according to the optical detection result, and receives the electrical signal reflecting the coagulation condition, and obtains the test blood sample after processing Measurement parameters.
  • an embodiment provides an optical method detection device, a magnetic bead method detection device, a test object transport mechanism, and a processor;
  • the optical method detection device is used to perform coagulation detection on the measured object based on the optical method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
  • the magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
  • the analyte transfer mechanism is used to transfer the reaction container containing the analyte to a preset position under the control of the processor;
  • the processor is used to obtain interference information reflecting the condition of the interference in the blood sample to be tested, and determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device performs coagulation detection on the test object according to the interference information And receive the electrical signal reflecting the coagulation situation, and obtain the measured parameters of the blood sample after processing.
  • the interfering substance refers to the substance that has an influence on the coagulation detection based on the optical method.
  • an embodiment provides a blood coagulation analyzer including: an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
  • the optical method detection device is used to perform coagulation detection on the measured object based on the optical method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
  • the magnetic bead method detection device is used to perform coagulation detection on the object under the control of the processor based on the magnetic bead method, and output an electrical signal reflecting the coagulation condition; the detection area of the magnetic bead method detection device and the optical method detection device are The same detection area;
  • the test object transfer mechanism is used to transfer the reaction container containing the test object to the common detection area under the control of the processor;
  • the processor is used to control the coagulation detection of the test object by the optical method detection device.
  • the optical method detection device detects inaccuracy or fails to output an electrical signal reflecting coagulation
  • the magnetic bead method detection device coagulates the test object Detection.
  • an embodiment provides a computer-readable storage medium including a program, where the program can be executed by a processor to implement the above method.
  • the blood sample analysis method and the coagulation analyzer of the above embodiment before the coagulation item test, first determine whether the sample is disturbed, and determine whether to use the optical method or the magnetic bead method to perform the coagulation item test according to the judgment result; or preferentially use the optical method Carry out blood coagulation test.
  • the optical method is used to detect the coagulation item of the sample; when the sample will affect the detection result of the coagulation test item based on the optical method, the magnetic beads are used Method for testing the blood coagulation items. This method solves the problem of inaccurate optical detection or inability to output detection results due to interference.
  • FIG. 1 is a schematic diagram of component modules of a coagulation analyzer according to an embodiment
  • FIG. 2 is a schematic structural diagram of a magnetic bead detection device according to an embodiment
  • 3a is a timing diagram of applying PWM waves to a driving coil according to an embodiment
  • FIG. 3b is a schematic diagram of an electric signal of magnetic bead movement according to an embodiment
  • FIG. 4 is a schematic structural diagram of an optical method detection device according to an embodiment
  • FIG. 5 is a spectral curve diagram of an interferer according to an embodiment
  • FIG. 6 is a schematic structural view of an embodiment where the optical method detection area and the magnetic bead method detection area are located in the same detection area;
  • FIG. 7 is a schematic diagram of multi-channel detection according to an embodiment
  • FIG. 8 is a flowchart of a blood sample analysis method according to an embodiment
  • FIG. 9 is a flowchart of an optical detection method according to an embodiment.
  • connection and “connection” mentioned in this application, unless otherwise specified, include direct and indirect connection (connection).
  • the optical method is used to detect the coagulation item of the sample; when the sample will affect the detection result of the coagulation test item based on the optical method, the magnetic beads are used Method for testing the blood coagulation items.
  • FIG. 1 shows a schematic structural diagram of a blood coagulation analyzer according to an embodiment of the present invention.
  • the blood coagulation analyzer includes a sample placement area 11, a sample collection mechanism 12, a reagent placement area 13, a reagent collection mechanism 14, and a reaction vessel
  • the placement area 10 the object transfer mechanism 15, the pre-judgment device 16, the optical method detection device 18, the magnetic bead method detection device 17, and the processor 19.
  • the sample placement area 11 is used to provide a place where the test sample 11a is placed.
  • the test sample may be plasma after removing blood cells, for example, plasma obtained by centrifuging the blood sample.
  • the sample placement area 11 is a rectangular area where multiple samples 11a can be placed. In an actual instrument, the sample placement area 11 may also be a bar-shaped or circular area, or it may be only a location where the sample is placed.
  • the reagent placement area 13 is used to provide a place where the test reagent 13a is placed.
  • the reagent placement area 13 is a rectangular area in which multiple test reagents 13a can be placed. In an actual instrument, the reagent placement area 13 may also be a bar or circular area.
  • the reagent includes at least one of a diluent, a mixed reagent, and a trigger reagent.
  • the reaction container placement area 10 is used to provide a place for placing the test reaction container 10a.
  • the reaction vessel placement area 10 is a rectangular area, and a plurality of reaction vessels 10a can be placed. In an actual instrument, the reaction vessel placement area 10 may also be a bar or circular area.
  • the sample collection mechanism 12 is used to collect the tested sample from the sample placement area 11 and add the measured sample to the reaction container 10a placed on the reaction container placement area 10
  • the reagent collection mechanism 14 is used to collect the reagent from the reagent placement area 13 And add the reagent to the reaction container 10a placed on the reaction container placement area 10.
  • the sample to be tested and the reagent are mixed and reacted in the reaction vessel 10a to form a sample.
  • the sample collection mechanism 12 and the reagent collection mechanism 14 may also be two-dimensional moving parts with a sampler, which can be collected in the sample placement area 11 or the reagent placement area 13 by two-dimensional movement in the plane
  • the tested sample or reagent is added to the reaction container 10a placed on the reaction container placement area 10.
  • the reaction container placement area 10 also has the function of incubation.
  • the sample to be tested and the reagent are mixed in the reaction container 10a and then placed on the reaction container placement area 10 for incubation. After the incubation is completed, the test object The transfer mechanism 15 transfers to the corresponding detection position for detection.
  • the reaction container placement area 10 does not have an incubation function. After the test sample and the reagent are mixed in the reaction container 10a, the test object transport mechanism 15 needs to be transferred to the incubation position for incubation.
  • the magnetic bead method detection device 17 is used to detect the coagulation item based on the magnetic bead method on the sample (analyte) mixed with the test sample and the reagent under the control of the processor, and output an electrical signal reflecting the coagulation condition to the processing ⁇ 19 ⁇ 19.
  • the area where the sample is tested for coagulation based on the magnetic bead method is called the magnetic bead method detection area.
  • the structure of the magnetic bead method detection device 17 is shown in FIG. 2, which may include a driving coil 210 and a measurement coil 220.
  • the structure of the reaction vessel used in the magnetic bead method is shown in FIG. 2.
  • the reaction container 200 is subjected to a cross-sectional process.
  • a magnetic bead 201 is placed in the accommodating chamber of the reaction container 200, and the bottom of the reaction container is provided for the magnetic bead 201 to move under the drive of a magnetic field.
  • the reaction container 200 has a length direction extending along the motion track of the magnetic beads and a width direction perpendicular to the length direction.
  • the magnetic bead is made of a material that can be quickly magnetized and demagnetized.
  • the magnetic bead When the magnetic bead is in a magnetic field, it can be quickly magnetized by the magnetic field. When the magnetic field disappears, the magnetic bead can be quickly demagnetized.
  • the shape of the magnetic bead may be spherical or other shapes, such as a polyhedron, which are only exemplified here and not specifically limited.
  • the detection device 16 may include an even array of drive coils 210, for example, there may be two sets of drive coils 210, and the two sets of drive coils 210 are located opposite each other at a certain distance, and are located on both sides of the reaction vessel 200 along the length of the reaction vessel 200, respectively. .
  • the two driving coils 210 are applied with PWM waves of the same period but different timing. As shown in FIG.
  • the period M1 and the period M2 are the periods during which the driving coil M1 and the driving coil M2 generate magnetic fields, respectively, thereby generating intermittent magnetic fields alternately (in During the period t1 and t2, the driving coil M1 generates a magnetic field in the illustrated period M1; during the period t3 and t4, the driving coil M2 generates a magnetic field in the illustrated period M2; and so on), the magnetization is repeated by the magnetic field
  • the beads cause the magnetic beads 201 in the reaction container 200 to oscillate along the orbit formed by the reaction container.
  • the detection device 16 may include an even-numbered array of measurement coils 220, for example, may include two sets of measurement coils 220, and the two sets of measurement coils 220 are located opposite each other at a certain distance, and are located on both sides of the reaction vessel 200 along the width direction of the reaction vessel 200, respectively. .
  • the two sets of measuring coils 220 are divided into a transmitting coil and a receiving coil.
  • the two ends of the transmitting coil are connected to a signal transmitting circuit (not shown in the figure), which is used to input a sine wave alternating current and used to generate a continuous magnetic field.
  • the two ends of the receiving coil are connected A signal receiving circuit (not shown in the figure) to detect the motion electrical signal generated by the oscillating motion of the magnetic bead 201.
  • the movement electrical signal refers to an electrical signal that can reflect the movement state of the magnetic bead 201.
  • the transmitting coil generates a magnetic field, and the magnetic beads cut the magnetic field lines to change the path of the magnetic field lines, thereby changing the magnetic flux received by the receiving coil.
  • the receiving coil generates the original induced electromotive force according to the received magnetic flux to generate a corresponding induced current.
  • the induced current undergoes circuit conversion and signal Conditioning can obtain a voltage signal containing motion information of the magnetic bead 201, that is, a motion electrical signal of the magnetic bead 201. Since the motion of the magnetic bead 201 changes the characteristics of the original induced current, the motion information of the magnetic bead 201 can be extracted from the changed induced current.
  • two sets of driving coils 210 and two sets of measuring coils 220 are arranged to cross each other, and the reaction vessel 200 is between two sets of driving coils 210 and at the same time between two sets of measuring coils 220.
  • the magnetic beads 201 can move in the sample to be tested in the reaction container 200.
  • the measuring coil 220 When the magnetic bead 201 moves in the reaction vessel 200, the measuring coil 220 generates a corresponding induced current, which reflects the movement of the magnetic bead 201 and can be used as the motion electrical signal of the magnetic bead 201.
  • the induced current generated by the measuring coil 220 may be converted to obtain a voltage signal, and the voltage signal may be used as the motion electrical signal of the magnetic bead 201.
  • the measurement coil 220 transmits the motion electric signal of the magnetic bead 201 obtained by the detection to the processor.
  • the measurement coil 220 may be connected to the processor through a signal conversion circuit (not shown) and a signal conditioning circuit (not shown).
  • the signal conversion circuit can perform analog-to-digital conversion on the motion electrical signal of the magnetic bead 201 acquired by the measuring coil 220 for at least a period of time
  • the signal conditioning circuit can be capable of converting the magnetic bead 201 acquired by the measurement coil 220 for at least a period of time.
  • the motion electric signal is preprocessed such as rectification, filtering and normalization. FIG.
  • 3b is a schematic diagram of the movement electrical signal of the magnetic bead 201 in a period of time in an embodiment, wherein the movement electrical signal of the magnetic bead 201 may be a voltage signal.
  • the magnetic bead 201 is in the reaction vessel Reciprocating motion within 200, the electric signal of the magnetic bead 201 in a period of time presents a sinusoidal distribution, as shown in the figure.
  • the optical method detection device 18 is used to detect the coagulation item based on the optical method of the sample (analyte) mixed with the test sample and the reagent under the control of the processor 19, and output an electrical signal reflecting the coagulation condition to the processor 19.
  • the area where the sample is tested for coagulation based on the optical method is called the optical detection area.
  • the structure of the optical method detection device 400 is shown in FIG. 4, and may include a light source 410 for performing optical method detection, a lens assembly 420, a filter 430 and a receiving unit 450.
  • a halogen lamp may be used as the light source 410.
  • the halogen lamp is accommodated in a lamp case having a plurality of heat sinks.
  • the heat sinks are used to cool the heat generated by the light source 410 due to heat generation.
  • the lens assembly 420 is composed of a plurality of condensers, and is used to converge and collimate the scattered light emitted by the light source 410.
  • the lens assembly 420 is disposed on the optical path that guides the light irradiated by the light source 410 to the sample 440 (object to be measured).
  • the filter 430 may be a disc shape, a polygon, etc. In a preferred embodiment, the filter 430 is a disc shape, which can be rotated around the center of the circle under the drive of a motor .
  • the filter 430 is provided with a plurality of holes. In one embodiment of the present application, six holes are provided on the filter 430 as an example for description. For other cases, refer to this embodiment for the same or similar applications. As shown in the figure, the hole 431 is a hole to block the opaque light, and the remaining five holes 432 are used to install five filters with different transmission wavelengths.
  • the five filters only transmit 340nm, 405nm, and 575nm, respectively , 660nm and 800nm light, other wavelengths of light are not transmitted, the hole 431 can be a spare hole, only need to add an optical film before installing the optical film.
  • the 6 holes are provided along the rotation direction of the filter 430 at a certain angular interval. With the rotation of the filter 430, the filter can be rotated to the optical path, so that the light only passes through the filter after passing through the filter Only the light with the matching wavelength of the film can pass through and illuminate the reaction container behind for optical detection.
  • the prothrombin time (PT) test item requires 405nm wavelength light to illuminate the sample, so The processor controls the motor to rotate the 405 nm wavelength filter on the filter 430 onto the optical path.
  • the thrombin time (TT) test item requires 660nm wavelength light to illuminate the sample, so the processor controls the motor to rotate the 660nm wavelength filter on the filter 430 to the optical path.
  • the receiving unit 450 is connected to the processor.
  • the receiving unit 450 is used to collect transmitted light and/or scattered light after the sample is irradiated with light of a specific wavelength, convert the optical signal into an electrical signal, and transmit the electrical signal to the processor. After the processor processes the electrical signal, the measurement parameters of the blood sample to be measured are obtained.
  • the optical method detection device 400 may not use the above halogen lamp solution, but adopt LEDs with multiple wavelengths, and combine the beams emitted by the multiple LEDs through a dichroic mirror corresponding to the LEDs.
  • a light combining prism is used to combine multiple wavelength beams, that is, the detection structure or detection method of the optical method detection device 400 is not limited, and details are not described herein again.
  • Fig. 5 is an exemplary hemoglobin, bilirubin, chyle and other interfering substances spectral curve, the horizontal axis is the wavelength (unit nm), the vertical axis is the absorbance, the inventor noticed that the three substances are different
  • the wavelength has different absorbances, reflecting that the three interferences have different absorption capabilities for light of different wavelengths, especially chyle, which has absorbance in the visible range of 340nm-790nm, which means that when the object contains When there is a large amount of chyle, irradiating the test object with visible light will absorb a large amount of light by the chyle, which will affect the results of coagulation detection based on the optical method.
  • a pre-judgment link is added before the formal coagulation test is performed to determine whether the sample to be tested contains an interferer that has an effect on the coagulation detection result based on the optical method.
  • the pre-judgment device 16 is used to perform optical detection on the test object before performing coagulation detection under the control of the processor 19 to obtain an optical detection result.
  • the test object detected by the pre-judgment device 16 contains at least the test sample, that is, the test object may be plasma, or a mixture of plasma and reagent (sample), and the reagent includes at least the diluent, mixed reagent, and trigger reagent.
  • the detection position where the pre-judgment device 16 optically detects the object may be a dedicated position, or may be an incubation area, an optical method detection area, or a magnetic bead method detection area.
  • the pre-judgment device 16 includes a photodetection device, and the photodetection device includes a light emitting end and a light receiving end, wherein the light emitting end is used to adopt at least one kind of specific wavelength light or the wavelength is close to the specific wavelength
  • the specific light refers to the wavelength of light used when the coagulation item is detected by the optical method.
  • the light receiving end is used to detect the optical information of the light of the test object after being subjected to light, to obtain the optical detection result of the test object for light of each specific wavelength.
  • the optical information may be the transmitted and/or scattered light intensity after the light beam passes through the measured object.
  • the light receiving end is signally connected to the processor 19, and is used to send the obtained optical detection result to the processor 19.
  • the light emitting end of the pre-judgment device 16 is connected to the optical method detection device, and the light beam that irradiates the object to be measured is the light beam that is filtered by the filter 430 and then split through the optical fiber; when the pre-judgment When the detection position where the device 16 optically detects the object is the optical detection area, the light filtered by the corresponding light-transmitting filter 430 can be directly irradiated to the object without a separate light source.
  • the light emitting end of the pre-judgment device 16 may also have a separate light source.
  • the pre-judgment device 16 includes an image acquisition device, the image acquisition device is used to collect image data (such as photos) of the object to be measured, to obtain an optical detection result, and send the optical detection result to the processor 19.
  • the image acquisition device may be a camera for capturing image data.
  • the processor 19 is used to obtain the interference information reflecting the condition of the interference in the blood sample to be tested, and to determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device performs coagulation on the test object based on the interference information Detect and receive the electrical signal reflecting the coagulation situation, and then process the electrical signal to obtain the measurement parameters of the blood sample to be measured.
  • the interfering substance refers to the substance that has an influence on the coagulation detection based on the optical method.
  • the processor 19 obtains interference information reflecting the condition of the interference in the test object according to the optical detection result.
  • the light emitting end of the pre-judgment device 16 is irradiated with light of at least one specific wavelength
  • the test object receives the transmitted light and/or scattered light of the test object after being irradiated with light
  • the processor 19 calculates the test object for each specific wavelength of light based on the optical information received from the light receiving end of the pre-judgment device 16
  • the absorbance value of at least one specific wavelength light is greater than the preset threshold value, it means that the sample will absorb the specific wavelength light, and the interference in the test object will be detected by the optical method for the detection of blood coagulation.
  • the preset threshold has different values for different specific wavelengths of light, which may be the system default setting value, or a value set by the user based on experience or experimental data.
  • the processor controls the optical method detection device to perform coagulation detection on the object based on the optical method; when the interference in the object will affect the detection result of the coagulation detection item based on the optical method, or
  • the processor controls the magnetic bead method detection device to perform coagulation detection on the object based on the magnetic bead method.
  • the interfering substance refers to a substance that absorbs light of a specific wavelength, wherein the specific wavelength refers to at least one
  • the test object may be irradiated with light close to a specific wavelength, and it may also be determined whether there is an interfering substance that will affect the detection result of the coagulation test item based on the optical method.
  • the processor 19 recognizes the color of the test object based on the image data (such as a photo) received from the pre-judgment device 16 and compares the color of the test object with the preset color.
  • the preset color is the color of the image data obtained when there is no interference in the test object, which can be the default color set by the system or the color set by the user based on experience or experimental data.
  • the processor controls the optical method detection device to perform coagulation detection on the test object; when the test object When the interfering substance in the test will affect the detection result of the coagulation detection item based on the optical method, the processor controls the magnetic bead method detection device to perform coagulation detection on the test object.
  • the optical detection area based on the optical method for coagulation detection and the magnetic bead detection area based on the magnetic bead method are the same detection area.
  • the reaction container used for the magnetic bead method for coagulation detection is the same device as the container for holding the sample which is used for the optical method for coagulation detection.
  • the magnetic beads need to be placed at the bottom of the reaction vessel.
  • the magnetic beads move under the drive of the driving coil, and the measurement coil obtains the movement of the magnetic beads according to the generated induced electromagnetic field.
  • the generated electrical signals are sent to the processor; when using the optical method for coagulation detection, there is no need to place magnetic beads in the reaction vessel, and the emission fiber uses at least one light of a specific wavelength or a light pair with a wavelength close to a specific wavelength
  • the test object in the reaction vessel is irradiated, and the receiving optical fiber transmits the received light information to the photoelectric conversion unit to obtain an electric signal.
  • the magnetic beads can only be placed in the reaction container when the magnetic bead method is used for detection, and there are no magnetic beads in the reaction container when the optical method is used for detection.
  • the coagulation analyzer also includes Pick-and-place device; of course, in some embodiments, the magnetic beads can always be placed in the reaction vessel. When performing optical detection, the magnetic beads will always remain at the bottom of the reaction vessel. In this case, the coagulation analyzer does not need to be used for pick-and-place Magnetic bead pick and place device.
  • the analyzer may also be provided with multiple detection areas as shown in FIG. 6 for detecting multiple samples at the same time, and each detection area may share an optical irradiation unit ,
  • the beam is directed to each detection area by a beam splitter to illuminate each object to be measured. If the position where the pre-judgment device performs optical detection on the object is not in this area, the beam can also be directed to the optical detection position (for example, dedicated position, incubation area, etc.) through the beam splitter.
  • the coagulation analyzer may not include a pre-judgment device, and the pre-judgment result of the sample to be tested may come from other modules connected online, that is, to obtain information reflecting the condition of interfering substances in the blood sample to be tested.
  • the information of interfering substances can come from other on-line instruments, and there is no need to install a pre-judgment device on the coagulation analyzer.
  • the optical method detection device detects inaccuracy or fails to output an electrical signal reflecting coagulation
  • the magnetic bead method detection device performs coagulation detection on the test object.
  • the blood coagulation analyzer in the above embodiments of the present application is mainly used for performing blood coagulation analysis on the test object.
  • the blood coagulation analyzer in the present application can use an optical method detection device to measure the object based on the optical method.
  • the magnetic bead method detection device can be used for the coagulation detection of the analyte based on the magnetic bead method.
  • the optical method can output the optical information curve in the test process, so that the result and the state of the instrument can be given more valuable judgment than the magnetic bead method, so the optical method is preferred in practical applications.
  • the magnetic bead method is used to detect the coagulation item, which can avoid the influence of the interfering substances on the coagulation detection results based on the optical method.
  • the blood sample analysis method of pre-judging the test object and then performing coagulation analysis includes the following steps:
  • Step 801 Start the blood sample analysis program of the coagulation analyzer.
  • Step 802 Obtain the test item for the blood sample to be tested, and determine whether the test item is a coagulation method item. If the test item is a coagulation method item, perform step 803. If the test item is not a coagulation method item, perform step 807. Select another method. The test object is tested and the test result is output.
  • Step 803 Perform optical detection on the test object contained in the reaction container to obtain an optical detection result, and obtain interference information reflecting the situation of the interference in the test object according to the optical detection result.
  • the specific wavelength used in the subsequent coagulation item test using the optical method can be known.
  • the specific wavelength is used one by one to the test objects contained in the reaction vessel Light irradiation, and collect the transmitted light and/or scattered light of the test object after light irradiation.
  • the test object contains at least the plasma of the blood sample to be tested, and the test object in this step may be plasma or a mixture of plasma and reagent.
  • the absorbance caused by the cascade reaction changes little at this time. Therefore, if this period of time is analyzed, the absorbance data of the sample can be obtained substantially accurately, so that the condition of the interfering substance can be judged.
  • a more obvious luminous flux baseline period will be formed.
  • the analyte undergoes a cascade of coagulation factors, so its luminous flux changes little and the luminous flux curve is flat.
  • the detected absorbance data is only the superposition of the absorbance data of the sample and the reagent absorbance data. Since the reagent absorbance data is known, the absorbance data of the sample to be tested can be obtained, so that the interference can be determined.
  • the luminous flux of the test sample is basically unchanged.
  • the absorbance data of the test sample before the trigger reagent is added is only the test sample and Superimposition of absorbance data of diluent and mixed reagent. Since the absorbance data of the diluent and mixed reagents are known, the absorbance data of the tested sample can be obtained, so that the condition of the interfering substances can be judged.
  • the diluent and mixed reagent are added first, followed by the trigger reagent. In some coagulation tests, it may not be necessary to add diluent and mixed reagents.
  • the process of optical detection of the measured object in this embodiment includes the following steps 901-903:
  • Step 901 Irradiate the test object with light of at least one wavelength.
  • the sample is irradiated with light of a specific wavelength to obtain optical information of scattered light and/or transmitted light after the beam irradiates the sample.
  • the setting time is set according to the type of reagent added to the sample to be tested and the time of adding the reagent.
  • the light beam comes from the optical method detection device. In another embodiment, it may also be a light source unique to the prediction device.
  • Step 902 Detect the optical information of the test object after being subjected to light.
  • the optical information includes the absorbance information of the test object.
  • the absorbance information is mainly the superposition of the absorbance data of the test sample and the absorbance data of the reagent. If the absorbance data of the reagent itself is subtracted from the absorbance information of the test sample, the measured value can be obtained.
  • the absorbance data of the sample Generally, the pre-judgment device detects the luminous flux data, where the luminous flux data includes the luminous flux data of the transmitted light and/or scattered light, and then the absorbance information is determined according to the luminous flux data and the initial luminous flux of the light source, and the absorbance information can be obtained according to the luminous flux data . Therefore, the optical information may also include luminous flux data of scattered light and/or transmitted light after the light beam illuminates the object.
  • interfering substances such as chyle, hemoglobin, and bilirubin have their own absorption spectra, they can be irradiated with multiple beams of different wavelengths. After irradiated with beams of each wavelength, they can be judged according to the absorbance value of the measured substance.
  • the situation of the corresponding interference for example, whether it contains interference.
  • light beams of various wavelengths can be used to irradiate the object to be measured, and the light beams of each wavelength correspond to three kinds of interfering substances, such as chyle, hemoglobin, and bilirubin, so that the corresponding interfering substances can be judged according to the absorbance values of the light beams of each wavelength. Therefore, in one of the embodiments, more than one wavelength beam is used to illuminate the object.
  • Step 903 Obtain the optical detection result of the test object according to the optical information.
  • the absorbance value of the test object for each specific wavelength of light is calculated.
  • the preset threshold value is obtained based on the predicted absorbance information of the reagent, the predicted absorbance information of the measured sample without interference, and the predicted ratio information of the tested sample and the reagent.
  • the absorbance information of the reagent and the ratio information of the sample to be tested and the reagent can be obtained from the setting information or detection parameters of the instrument, so it is foreseeable.
  • the ratio information may be volume ratio information or weight ratio information.
  • the optical detection further includes: collecting image data (such as a photo) of the measured object, obtaining color information based on the image data, and obtaining interference information reflecting the condition of the interference in the measured object according to the color information to obtain Optical inspection results.
  • image data such as a photo
  • interference information reflecting the condition of the interference in the measured object according to the color information to obtain Optical inspection results.
  • the prompt information and/or the alarm information may also be issued according to the interference in the tested sample.
  • the prompt information and/or the alarm information may include: Prompt information and/or warning information of the interference in the system, or prompt information that determines to use the optical method or the magnetic bead method.
  • step 804 may be performed.
  • Step 804 According to the interference information, determine whether it will affect the detection result of the coagulation detection item based on the optical method, and determine the coagulation detection method used for the blood sample to be tested.
  • Step 806 is executed when the detection result of the coagulation detection item has an influence
  • step 805 is executed when the interference in the test object has an influence on the detection result of the coagulation detection item based on the optical method.
  • Step 805 The processor controls the magnetic bead method detection device to perform coagulation detection on the test object based on the magnetic bead method, output an electrical signal reflecting the coagulation status, and process the electrical signal to obtain the measurement parameters of the blood sample to be measured.
  • Step 806 The processor controls the optical method detection device to perform coagulation detection on the test object based on the optical method, output an electrical signal reflecting the coagulation status, and process the electrical signal to obtain the measurement parameters of the blood sample to be measured.
  • the method of step 803 may not be used for optical detection of the test object, but the optical method detection device may be used for direct detection of the blood coagulation of the test object.
  • the detection device detects inaccuracy or fails to output an electrical signal reflecting the coagulation situation, the magnetic bead method detection device is then used to detect the coagulation of the test object.
  • the present application also provides a coagulation analyzer according to an embodiment, which is used to measure and analyze the number of specific substances related to blood coagulation/fibrinolysis function and the degree of activity thereof, and the specimen is plasma.
  • the coagulation analyzer of the present embodiment measures the specimen by the clotting time method, the chromogenic substrate method, and the immunoturbidimetric method.
  • the coagulation time method used in this embodiment is a measurement method that uses the coagulation process of a specimen as a change in transmitted light detection or a motion change of a magnetic bead in a specimen driven by a magnetic force.
  • the measurement items of the clotting time method include PT (prothrombin time), APTT (activated partial thrombin time), TT (thrombin time), and FIB (fibrinogen amount).
  • the measurement items of the chromogenic substrate method include AT-III (antithrombin III), etc.
  • the measurement items of the immunoturbidimetric method include D-Dimer (D-dimer) and FDP.
  • any tangible, non-transitory computer-readable storage medium can be used, including magnetic storage devices (hard disks, floppy disks, etc.), optical storage devices (CD-ROM, DVD, Blu Ray disks, etc.), flash memory, and/or the like .
  • These computer program instructions can be loaded onto a general purpose computer, special purpose computer, or other programmable data processing equipment to form a machine, so that these instructions executed on a computer or other programmable data processing device can generate a device that implements a specified function.
  • Computer program instructions can also be stored in a computer-readable memory, which can instruct the computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory can form a piece Manufactured products, including implementation devices that implement specified functions.
  • Computer program instructions can also be loaded onto a computer or other programmable data processing device, so that a series of operating steps are performed on the computer or other programmable device to produce a computer-implemented process that allows the computer or other programmable device to execute Instructions can provide steps for implementing specified functions.

Abstract

Disclosed are a blood sample analysis method and a blood coagulation analyzer. The blood sample analysis method based on the blood coagulation analyzer comprises: performing optical detection on an object to be detected contained in a reaction vessel to obtain an optical detection result, wherein the object to be detected comprises at least the plasma of a blood sample to be detected; obtaining interferent information reflecting the interferents in the object to be detected based on the optical detection result (803); determining a blood coagulation detection method for the blood sample to be detected based on the interferent information (804); when the interferents in the object to be detected do not influence a detection result of a blood coagulation detection item based on an optical method, performing a blood coagulation detection on the object to be detected based on the optical method (806); and when the interferents in the object to be detected influence the detection result of the blood coagulation detection item based on the optical method, performing the blood coagulation detection on the object to be detected based on a magnetic bead method (805).

Description

一种血样分析方法及凝血分析仪Blood sample analysis method and coagulation analyzer 技术领域Technical field
本发明涉及一种医疗设备,具体涉及一种血样分析方法及凝血分析仪。The invention relates to a medical device, in particular to a blood sample analysis method and a blood coagulation analyzer.
背景技术Background technique
凝血分析仪用于医疗临床上测量人体血液中各种成分含量,定量生物化学分析结果,为临床诊断患者各种疾病提供可靠数字依据。现有凝血分析仪的测量方法主要有凝固法、免疫比浊法和发色底物法等。其中,凝固法是通过检测血浆在触发试剂(也称为凝血激活剂)作用下的一系列物理量(光、电、机械运动等)的变化,再由计算机分析所得数据并将之换算成最终结果。目前,凝固法在具体实现方式上通常可以分为磁珠法和光学法,主要应用于凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、凝血酶时间(TT)以及相关凝血因子等衍生项目的检测。The blood coagulation analyzer is used to measure the content of various components in human blood in clinical medicine and quantify the results of biochemical analysis, providing a reliable digital basis for clinical diagnosis of various diseases in patients. The measurement methods of the existing coagulation analyzer mainly include coagulation method, immunoturbidimetry method and chromogenic substrate method. Among them, the coagulation method is to detect the change of a series of physical quantities (light, electricity, mechanical motion, etc.) of plasma under the action of a triggering reagent (also called coagulation activator), and then analyze the data obtained by the computer and convert it into the final result . At present, the specific implementation of coagulation method can usually be divided into magnetic bead method and optical method, which are mainly used in prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), thrombin Time (TT) and related coagulation factor and other derivative testing.
由于磁珠法和光学法是在检测原理和检测部件上都不同的两套独立的检测方法,因此目前的主流仪器厂商在凝固法实现方式的选择上,要么采用磁珠法,比如斯达高(STAGO)公司,要么采用光学法,比如沃芬(IL)公司和希森美康(SYSMEX)公司。Since the magnetic bead method and the optical method are two independent detection methods that are different in detection principle and detection components, the current mainstream instrument manufacturers either use the magnetic bead method, such as Stargo, in the choice of the coagulation method implementation method (STAGO) companies, either using optical methods, such as Wolfen (IL) and Sysmex (SYSMEX).
磁珠法是直接利用凝血反应后,血浆中纤维蛋白原转变为纤维蛋白,血浆中的粘稠度增加,通过探测试杯中磁珠的摆动幅度变化来获得测试结果。The magnetic bead method directly uses the coagulation reaction, and the fibrinogen in the plasma is converted into fibrin, and the viscosity in the plasma is increased. The test result is obtained by detecting the swing amplitude of the magnetic bead in the test cup.
光学法是利用光学原理探测试杯中被测试样浊度的变化。其优点是能够输出测试过程中的光学信息曲线,从而对结果和仪器状态能够给出相对于磁珠法更多有价值的判断。但光学法的缺点是容易受到样本本身颜色的干扰,从而不能得到正确的结果或者不能输出结果。如图5所示为一种示例性的血红蛋白、胆红素、乳糜等干扰物的光谱曲线图,横轴为波长(单位nm),纵轴为吸光度,通过观察可以发现,三种物质在不同的波长处具有不同的吸光度,反应了三种干扰物对不同波长的光具有不同的吸收能力,特别是乳糜,其在可见光范围340nm-790nm之间都具有吸光度,意味着当被测物中含有大量乳糜时,用可见光对被测物进行照射将有大量的光被乳糜吸收,从而影响光学法进行凝血检测的结果。The optical method is to use the optical principle to probe the change of the turbidity of the test sample in the test cup. Its advantage is that it can output the optical information curve in the test process, so that it can give more valuable judgments on the results and instrument status compared with the magnetic bead method. However, the disadvantage of the optical method is that it is easily interfered by the color of the sample itself, so that the correct result cannot be obtained or the result cannot be output. As shown in Figure 5 is an exemplary hemoglobin, bilirubin, chylous and other interfering substances spectral curve, the horizontal axis is the wavelength (unit nm), the vertical axis is the absorbance, through observation can be found that the three substances are different The wavelength has different absorbances, reflecting that the three interferences have different absorption capabilities for light of different wavelengths, especially chyle, which has absorbance in the visible range of 340nm-790nm, which means that when the object contains When there is a large amount of chyle, irradiating the test object with visible light will absorb a large amount of light by the chyle, which will affect the results of the optical method for blood coagulation detection.
技术问题technical problem
本发明主要提供一种血样分析方法及凝血分析仪,基于该凝血分析仪的血样分析方法在凝血项目检测前,先判断样本是否有干扰,根据判断结果确定是应用光学法还是磁珠法来进行凝血项目检测,解决了由于干扰导致光学法检测不准确或不能输出检测结果的问题。The invention mainly provides a blood sample analysis method and a blood coagulation analyzer. Before the blood coagulation item is detected, the blood sample analysis method based on the blood coagulation analyzer first determines whether the sample has interference, and determines whether to use the optical method or the magnetic bead method according to the judgment result Coagulation test, which solves the problem of inaccurate optical detection or inability to output test results due to interference.
技术解决方案Technical solution
根据第一方面,一种实施例中提供一种血样分析方法,包括:According to a first aspect, an embodiment provides a blood sample analysis method, including:
对盛装在反应容器中的被测物进行光学检测,得到光学检测结果,被测物至少包含有被测血样的血浆;Perform optical detection on the test object contained in the reaction vessel to obtain an optical test result. The test object contains at least the plasma of the blood sample;
根据光学检测结果得到反映被测物中干扰物情况的干扰物信息,其中干扰物是指对基于光学法的凝血检测项目的检测结果有影响的物质; Obtain interference information reflecting the situation of interfering substances in the test object according to the optical detection results, where interfering substances refer to substances that have an influence on the detection result of the blood coagulation detection item based on the optical method;
根据干扰物信息确定对被测血样采用的凝血检测方法;Determine the coagulation detection method for the blood sample to be tested according to the information of the interference;
当被测物中的干扰物不会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制光学法检测装置对被测物基于光学法进行凝血检测;When the interference in the test object does not affect the detection result of the coagulation test item based on the optical method, the processor controls the optical method detection device to perform the coagulation test on the test object based on the optical method;
当被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制磁珠法检测装置对被测物基于磁珠法进行凝血检测。When the interference in the test object will affect the detection result of the coagulation detection item based on the optical method, the processor controls the magnetic bead method detection device to perform the coagulation detection on the test object based on the magnetic bead method.
根据第二方面,一种实施例中提供一种基于凝血分析仪的血样分析方法,包括:According to a second aspect, an embodiment provides a blood sample analysis method based on a coagulation analyzer, including:
获取反映被测血样中干扰物情况的干扰物信息,干扰物是指对基于光学法的凝血检测有影响的物质;Obtain the information of interfering substances reflecting the situation of interfering substances in the blood sample to be tested. Interfering substances refer to substances that have an influence on the coagulation detection based on optical method;
根据干扰物信息判断是基于光学法还是磁珠法对该被测血样进行凝血检测。According to the interference information, it is determined whether the blood sample to be tested is coagulated based on the optical method or the magnetic bead method.
根据第三方面,一种实施例中提供一种凝血分析仪,包括预判装置、光学法检测装置、磁珠法检测装置、被测物转运机构和处理器;According to a third aspect, an embodiment provides a coagulation analyzer including a pre-judgment device, an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
预判装置用于在处理器的控制下对被测物在其进行凝血检测之前先进行光学检测,得到光学检测结果,被测物至少包含有被测血样的血浆;The pre-judgment device is used to perform optical detection on the test object before performing the coagulation test under the control of the processor to obtain an optical detection result. The test object contains at least the plasma of the blood sample;
光学法检测装置用于在处理器的控制下对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号;The optical method detection device is used to perform coagulation detection on the measured object based on the optical method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
磁珠法检测装置用于在处理器的控制下对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号;The magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
被测物转运机构用于在处理器的控制下将容纳有被测物反应容器转运到预设的位置;The analyte transfer mechanism is used to transfer the reaction container containing the analyte to a preset position under the control of the processor;
处理器用于根据光学检测结果确定由光学法检测装置对被测物进行凝血检测还是磁珠法检测装置对被测物进行凝血检测,并接收反映凝固情况的电信号,处理后得到被测血样的测量参数。The processor is used to determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device performs coagulation detection on the test object according to the optical detection result, and receives the electrical signal reflecting the coagulation condition, and obtains the test blood sample after processing Measurement parameters.
根据第四方面,一种实施例中提供一种包括光学法检测装置、磁珠法检测装置、被测物转运机构和处理器;According to a fourth aspect, an embodiment provides an optical method detection device, a magnetic bead method detection device, a test object transport mechanism, and a processor;
光学法检测装置用于在处理器的控制下对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号;The optical method detection device is used to perform coagulation detection on the measured object based on the optical method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
磁珠法检测装置用于在处理器的控制下对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号;The magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
被测物转运机构用于在处理器的控制下将容纳有被测物反应容器转运到预设的位置;The analyte transfer mechanism is used to transfer the reaction container containing the analyte to a preset position under the control of the processor;
处理器用于获取反映被测血样中干扰物情况的干扰物信息,根据所述干扰物信息判断是由光学法检测装置对被测物进行凝血检测还是磁珠法检测装置对被测物进行凝血检测,并接收反映凝固情况的电信号,处理后得到被测血样的测量参数,干扰物是指对基于光学法的凝血检测有影响的物质。The processor is used to obtain interference information reflecting the condition of the interference in the blood sample to be tested, and determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device performs coagulation detection on the test object according to the interference information And receive the electrical signal reflecting the coagulation situation, and obtain the measured parameters of the blood sample after processing. The interfering substance refers to the substance that has an influence on the coagulation detection based on the optical method.
根据第五方面,一种实施例中提供一种凝血分析仪包括:光学法检测装置、磁珠法检测装置、被测物转运机构和处理器;According to a fifth aspect, an embodiment provides a blood coagulation analyzer including: an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
光学法检测装置用于在处理器的控制下对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号;The optical method detection device is used to perform coagulation detection on the measured object based on the optical method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
磁珠法检测装置用于在处理器的控制下对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号;磁珠法检测装置的检测区域和光学法检测装置的检测区域是同一检测区域;The magnetic bead method detection device is used to perform coagulation detection on the object under the control of the processor based on the magnetic bead method, and output an electrical signal reflecting the coagulation condition; the detection area of the magnetic bead method detection device and the optical method detection device are The same detection area;
被测物转运机构用于在处理器的控制下将容纳有被测物反应容器转运到共用检测区域;The test object transfer mechanism is used to transfer the reaction container containing the test object to the common detection area under the control of the processor;
处理器用于控制先由光学法检测装置对被测物进行凝血检测,在光学法检测装置检测不准确或不能输出反映凝固情况的电信号时,再由磁珠法检测装置对被测物进行凝血检测。The processor is used to control the coagulation detection of the test object by the optical method detection device. When the optical method detection device detects inaccuracy or fails to output an electrical signal reflecting coagulation, the magnetic bead method detection device coagulates the test object Detection.
根据第六方面,一种实施例中提供一种计算机可读存储介质,包括程序,其中程序能够被处理器执行以实现上述方法。According to a sixth aspect, an embodiment provides a computer-readable storage medium including a program, where the program can be executed by a processor to implement the above method.
有益效果Beneficial effect
依据上述实施例的血样分析方法及凝血分析仪,在凝血项目检测前,先判断样本是否有干扰,根据判断结果确定是应用光学法还是磁珠法来进行凝血项目检测;或者优先用光学法来进行凝血项目检测。当样本不会对基于光学法的凝血检测项目的检测结果有影响时,采用光学法对样本进行凝血项目检测;当样本会对基于光学法的凝血检测项目的检测结果有影响时,采用磁珠法对样本进行凝血项目检测。该方法解决了由于干扰导致光学法检测不准确或不能输出检测结果的问题。According to the blood sample analysis method and the coagulation analyzer of the above embodiment, before the coagulation item test, first determine whether the sample is disturbed, and determine whether to use the optical method or the magnetic bead method to perform the coagulation item test according to the judgment result; or preferentially use the optical method Carry out blood coagulation test. When the sample does not affect the detection result of the coagulation test item based on the optical method, the optical method is used to detect the coagulation item of the sample; when the sample will affect the detection result of the coagulation test item based on the optical method, the magnetic beads are used Method for testing the blood coagulation items. This method solves the problem of inaccurate optical detection or inability to output detection results due to interference.
附图说明BRIEF DESCRIPTION
图1为一种实施例的凝血分析仪的组成模块示意图;FIG. 1 is a schematic diagram of component modules of a coagulation analyzer according to an embodiment;
图2为一种实施例的磁珠法检测装置的结构示意图;2 is a schematic structural diagram of a magnetic bead detection device according to an embodiment;
图3a为一种实施例的对驱动线圈施加PWM波的时序图;3a is a timing diagram of applying PWM waves to a driving coil according to an embodiment;
图3b为一种实施例的磁珠运动电信号的示意图;FIG. 3b is a schematic diagram of an electric signal of magnetic bead movement according to an embodiment;
图4为一种实施例的光学法检测装置的结构示意图;4 is a schematic structural diagram of an optical method detection device according to an embodiment;
图5为一种实施例的干扰物的光谱曲线图; FIG. 5 is a spectral curve diagram of an interferer according to an embodiment;
图6为一种实施例的光学法检测区域与磁珠法检测区域位于同一检测区域的结构示意图; 6 is a schematic structural view of an embodiment where the optical method detection area and the magnetic bead method detection area are located in the same detection area;
图7为一种实施例的多通道检测示意图;7 is a schematic diagram of multi-channel detection according to an embodiment;
图8为一种实施例的血样分析方法的流程图;8 is a flowchart of a blood sample analysis method according to an embodiment;
图9为一种实施例的光学检测方法的流程图。9 is a flowchart of an optical detection method according to an embodiment.
本发明的实施方式Embodiments of the invention
具体实施方式detailed description
下面通过具体实施方式结合附图对本发明作进一步详细说明。其中不同实施方式中类似元件采用了相关联的类似的元件标号。在以下的实施方式中,很多细节描述是为了使得本申请能被更好的理解。然而,本领域技术人员可以毫不费力的认识到,其中部分特征在不同情况下是可以省略的,或者可以由其他元件、材料、方法所替代。在某些情况下,本申请相关的一些操作并没有在说明书中显示或者描述,这是为了避免本申请的核心部分被过多的描述所淹没,而对于本领域技术人员而言,详细描述这些相关操作并不是必要的,他们根据说明书中的描述以及本领域的一般技术知识即可完整了解相关操作。The present invention will be further described in detail below through specific embodiments and drawings. Corresponding similar element labels are used for similar elements in different embodiments. In the following embodiments, many details are described so that the present application can be better understood. However, those skilled in the art can easily recognize that some of the features may be omitted in different situations, or may be replaced by other elements, materials, and methods. In some cases, some operations related to this application are not shown or described in the specification. This is to avoid the core part of this application being overwhelmed by too many descriptions. For those skilled in the art, describe these in detail Related operations are not necessary, they can fully understand related operations according to the description in the specification and general technical knowledge in the field.
另外,说明书中所描述的特点、操作或者特征可以以任意适当的方式结合形成各种实施方式。同时,方法描述中的各步骤或者动作也可以按照本领域技术人员所能显而易见的方式进行顺序调换或调整。因此,说明书和附图中的各种顺序只是为了清楚描述某一个实施例,并不意味着是必须的顺序,除非另有说明其中某个顺序是必须遵循的。In addition, the features, operations, or characteristics described in the specification may be combined in any appropriate manner to form various embodiments. At the same time, the steps or actions in the method description can also be sequentially replaced or adjusted in a manner obvious to those skilled in the art. Therefore, the various orders in the specification and the drawings are only for clearly describing a certain embodiment, and are not meant to be a necessary order, unless otherwise stated that a certain order must be followed.
本文中为部件所编序号本身,例如“第一”、“第二”等,仅用于区分所描述的对象,不具有任何顺序或技术含义。而本申请所说“连接”、“联接”,如无特别说明,均包括直接和间接连接(联接)。The serial numbers themselves, such as "first", "second", etc., are used to distinguish the described objects, and do not have any order or technical meaning. The "connection" and "connection" mentioned in this application, unless otherwise specified, include direct and indirect connection (connection).
 A
在本发明实施例中,在凝血项目检测前,先判断样本是否有干扰,根据判断结果确定是应用光学法还是磁珠法来进行凝血项目检测。当样本不会对基于光学法的凝血检测项目的检测结果有影响时,采用光学法对样本进行凝血项目检测;当样本会对基于光学法的凝血检测项目的检测结果有影响时,采用磁珠法对样本进行凝血项目检测。In the embodiment of the present invention, before detecting the coagulation item, it is first determined whether the sample is disturbed, and it is determined whether to apply the optical method or the magnetic bead method to perform the coagulation item detection according to the determination result. When the sample does not affect the detection result of the coagulation test item based on the optical method, the optical method is used to detect the coagulation item of the sample; when the sample will affect the detection result of the coagulation test item based on the optical method, the magnetic beads are used Method for testing the blood coagulation items.
请参考图1,图1示出了本发明一种实施例中凝血分析仪的结构示意图,凝血分析仪包括样本放置区11、样本采集机构12、试剂放置区13、试剂采集机构14、反应容器放置区10、被测物转运机构15、预判装置16、光学法检测装置18、磁珠法检测装置17和处理器19。Please refer to FIG. 1, which shows a schematic structural diagram of a blood coagulation analyzer according to an embodiment of the present invention. The blood coagulation analyzer includes a sample placement area 11, a sample collection mechanism 12, a reagent placement area 13, a reagent collection mechanism 14, and a reaction vessel The placement area 10, the object transfer mechanism 15, the pre-judgment device 16, the optical method detection device 18, the magnetic bead method detection device 17, and the processor 19.
样本放置区11用于提供被测样本11a放置的场所,被测样本可以是经去除血细胞后的血浆,例如将血液样本经离心处理后得到的血浆。图示中,样本放置区11是一个矩形区域,可放置多个被测样本11a。实际仪器中,样本放置区11也可以是一个条形或圆形区域,也可以仅是一个放置样本的位置。The sample placement area 11 is used to provide a place where the test sample 11a is placed. The test sample may be plasma after removing blood cells, for example, plasma obtained by centrifuging the blood sample. In the illustration, the sample placement area 11 is a rectangular area where multiple samples 11a can be placed. In an actual instrument, the sample placement area 11 may also be a bar-shaped or circular area, or it may be only a location where the sample is placed.
试剂放置区13用于提供放置测试用试剂13a的场所。图示中,试剂放置区13是一个矩形区域,可放置多个测试用试剂13a。实际仪器中,试剂放置区13也可以是一个条形或圆形区域。试剂包括稀释液、混合试剂和触发试剂中的至少一种。The reagent placement area 13 is used to provide a place where the test reagent 13a is placed. In the illustration, the reagent placement area 13 is a rectangular area in which multiple test reagents 13a can be placed. In an actual instrument, the reagent placement area 13 may also be a bar or circular area. The reagent includes at least one of a diluent, a mixed reagent, and a trigger reagent.
反应容器放置区10用于提供放置测试用反应容器10a的场所。图示中,反应容器放置区10是一个矩形区域,可放置多个反应容器10a。实际仪器中,反应容器放置区10也可以是一个条形或圆形区域。The reaction container placement area 10 is used to provide a place for placing the test reaction container 10a. In the illustration, the reaction vessel placement area 10 is a rectangular area, and a plurality of reaction vessels 10a can be placed. In an actual instrument, the reaction vessel placement area 10 may also be a bar or circular area.
样本采集机构12用于从样本放置区11采集被测样本,并将被测样本添加到放置在反应容器放置区10上的反应容器10a中,试剂采集机构14用于从试剂放置区13采集试剂,并将试剂添加到放置在反应容器放置区10上的反应容器10a中。被测样本和试剂在反应容器10a中混合反应以形成试样。在有的实施例中,样本采集机构12和试剂采集机构14也可以是带有采样器的二维运动部件,通过在平面内做二维移动将在样本放置区11或试剂放置区13采集到的被测样本或试剂添加到放置在反应容器放置区10上的反应容器10a中。The sample collection mechanism 12 is used to collect the tested sample from the sample placement area 11 and add the measured sample to the reaction container 10a placed on the reaction container placement area 10, and the reagent collection mechanism 14 is used to collect the reagent from the reagent placement area 13 And add the reagent to the reaction container 10a placed on the reaction container placement area 10. The sample to be tested and the reagent are mixed and reacted in the reaction vessel 10a to form a sample. In some embodiments, the sample collection mechanism 12 and the reagent collection mechanism 14 may also be two-dimensional moving parts with a sampler, which can be collected in the sample placement area 11 or the reagent placement area 13 by two-dimensional movement in the plane The tested sample or reagent is added to the reaction container 10a placed on the reaction container placement area 10.
在一种具体实施例中,反应容器放置区10也具有孵育的功能,被测样本和试剂在反应容器10a中混合后继续放置在反应容器放置区10上进行孵育,孵育完成后由被测物转运机构15转运到相应的检测位置进行检测。在有的实施例中,反应容器放置区10不具有孵育的功能,被测样本和试剂在反应容器10a中混合后还需要由被测物转运机构15转运到孵育位置进行孵育。In a specific embodiment, the reaction container placement area 10 also has the function of incubation. The sample to be tested and the reagent are mixed in the reaction container 10a and then placed on the reaction container placement area 10 for incubation. After the incubation is completed, the test object The transfer mechanism 15 transfers to the corresponding detection position for detection. In some embodiments, the reaction container placement area 10 does not have an incubation function. After the test sample and the reagent are mixed in the reaction container 10a, the test object transport mechanism 15 needs to be transferred to the incubation position for incubation.
磁珠法检测装置17用于在处理器的控制下对由被测样本和试剂混合后的试样(被测物)基于磁珠法进行凝血项目检测,并输出反映凝固情况的电信号至处理器19。基于磁珠法对试样进行凝血项目检测的区域称为磁珠法检测区域。The magnetic bead method detection device 17 is used to detect the coagulation item based on the magnetic bead method on the sample (analyte) mixed with the test sample and the reagent under the control of the processor, and output an electrical signal reflecting the coagulation condition to the processing器19。 19. The area where the sample is tested for coagulation based on the magnetic bead method is called the magnetic bead method detection area.
一种实施例中,磁珠法检测装置17的结构如图2所示,可以包括驱动线圈210和测量线圈220,磁珠法采用的反应容器的结构如图2所示,为方便看清结构,图2中对反应容器200进行了剖视处理。反应容器200的容纳腔内放置有磁珠201,反应容器的底部供磁珠201在磁场的驱动下运动。为方便描述,反应容器200具有沿磁珠运动轨道延伸的长度方向和与长度方向垂直的宽度方向。在本申请实施例中,磁珠采用能够被快速磁化和消磁的材料制成,当磁珠处于磁场中时,它能够被磁场快速磁化,当磁场消失后,磁珠能够快速去磁。该磁珠的形状可以采用球形,也可以采用其他形状,例如多面体,此处仅举例说明,不做具体限定。可选地,检测装置16可以包括偶数组驱动线圈210,例如驱动线圈210可以有两组,两组驱动线圈210间隔一定距离相对设置,分别沿反应容器200的长度方向位于反应容器200的两侧。两个驱动线圈210被施加以周期相同但时序不同的PWM波,如图3a所示,时段M1和时段M2为分别驱动线圈M1和驱动线圈M2产生磁场的时段,从而交替产生间歇式磁场(在t1和t2这段期间,驱动线圈M1在图示的时段M1中产生磁场;在t3和t4这段期间,驱动线圈M2在图示的时段M2中产生磁场;如此类推),通过磁场反复磁化磁珠使得反应容器200内的磁珠201沿反应容器形成的轨道进行振荡运动。In one embodiment, the structure of the magnetic bead method detection device 17 is shown in FIG. 2, which may include a driving coil 210 and a measurement coil 220. The structure of the reaction vessel used in the magnetic bead method is shown in FIG. 2. In FIG. 2, the reaction container 200 is subjected to a cross-sectional process. A magnetic bead 201 is placed in the accommodating chamber of the reaction container 200, and the bottom of the reaction container is provided for the magnetic bead 201 to move under the drive of a magnetic field. For convenience of description, the reaction container 200 has a length direction extending along the motion track of the magnetic beads and a width direction perpendicular to the length direction. In the embodiment of the present application, the magnetic bead is made of a material that can be quickly magnetized and demagnetized. When the magnetic bead is in a magnetic field, it can be quickly magnetized by the magnetic field. When the magnetic field disappears, the magnetic bead can be quickly demagnetized. The shape of the magnetic bead may be spherical or other shapes, such as a polyhedron, which are only exemplified here and not specifically limited. Optionally, the detection device 16 may include an even array of drive coils 210, for example, there may be two sets of drive coils 210, and the two sets of drive coils 210 are located opposite each other at a certain distance, and are located on both sides of the reaction vessel 200 along the length of the reaction vessel 200, respectively. . The two driving coils 210 are applied with PWM waves of the same period but different timing. As shown in FIG. 3a, the period M1 and the period M2 are the periods during which the driving coil M1 and the driving coil M2 generate magnetic fields, respectively, thereby generating intermittent magnetic fields alternately (in During the period t1 and t2, the driving coil M1 generates a magnetic field in the illustrated period M1; during the period t3 and t4, the driving coil M2 generates a magnetic field in the illustrated period M2; and so on), the magnetization is repeated by the magnetic field The beads cause the magnetic beads 201 in the reaction container 200 to oscillate along the orbit formed by the reaction container.
可选地,检测装置16可以包括偶数组测量线圈220,例如可以包括两组测量线圈220,两组测量线圈220间隔一定距离相对设置,分别沿反应容器200的宽度方向位于反应容器200的两侧。两组测量线圈220分为发射线圈和接收线圈,发射线圈的两端连接信号发射电路(图中未示出),用于输入正弦波交流电,用于产生连续的磁场,接收线圈的两端连接信号接收电路(图中未示出),以检测磁珠201的振荡运动而产生的运动电信号。所述的运动电信号,是指能够反映磁珠201运动状态的电信号。发射线圈产生磁场,磁珠切割磁力线运动,改变磁力线的路径,从而改变接收线圈接收到的磁通量,接收线圈根据接收到的磁通量产生原感应电动势产生相应的感应电流,该感应电流经过电路转换和信号调理,能够得到包含磁珠201运动信息的电压信号,即磁珠201的运动电信号。由于磁珠201的运动,改变了原感应电流的特征,因而可从改变后的感应电流中可以提取出磁珠201的运动信息。Optionally, the detection device 16 may include an even-numbered array of measurement coils 220, for example, may include two sets of measurement coils 220, and the two sets of measurement coils 220 are located opposite each other at a certain distance, and are located on both sides of the reaction vessel 200 along the width direction of the reaction vessel 200, respectively. . The two sets of measuring coils 220 are divided into a transmitting coil and a receiving coil. The two ends of the transmitting coil are connected to a signal transmitting circuit (not shown in the figure), which is used to input a sine wave alternating current and used to generate a continuous magnetic field. The two ends of the receiving coil are connected A signal receiving circuit (not shown in the figure) to detect the motion electrical signal generated by the oscillating motion of the magnetic bead 201. The movement electrical signal refers to an electrical signal that can reflect the movement state of the magnetic bead 201. The transmitting coil generates a magnetic field, and the magnetic beads cut the magnetic field lines to change the path of the magnetic field lines, thereby changing the magnetic flux received by the receiving coil. The receiving coil generates the original induced electromotive force according to the received magnetic flux to generate a corresponding induced current. The induced current undergoes circuit conversion and signal Conditioning can obtain a voltage signal containing motion information of the magnetic bead 201, that is, a motion electrical signal of the magnetic bead 201. Since the motion of the magnetic bead 201 changes the characteristics of the original induced current, the motion information of the magnetic bead 201 can be extracted from the changed induced current.
如图2所示,在一个实施例中,两组驱动线圈210和两组测量线圈220相互交叉设置,反应容器200处于两组驱动线圈210之间并且同时处于两组测量线圈220之间。在驱动电磁场的作用下,磁珠201能够在反应容器200内的待测样本中运动。As shown in FIG. 2, in one embodiment, two sets of driving coils 210 and two sets of measuring coils 220 are arranged to cross each other, and the reaction vessel 200 is between two sets of driving coils 210 and at the same time between two sets of measuring coils 220. Under the action of the driving electromagnetic field, the magnetic beads 201 can move in the sample to be tested in the reaction container 200.
当磁珠201在反应容器200内运动时,该测量线圈220产生相应的感应电流,该感应电流反映了该磁珠201运动情况,可以作为该磁珠201的运动电信号。当然,也可以对测量线圈220产生的感应电流进行转换后获得电压信号,并将该电压信号作为该磁珠201的运动电信号。When the magnetic bead 201 moves in the reaction vessel 200, the measuring coil 220 generates a corresponding induced current, which reflects the movement of the magnetic bead 201 and can be used as the motion electrical signal of the magnetic bead 201. Of course, the induced current generated by the measuring coil 220 may be converted to obtain a voltage signal, and the voltage signal may be used as the motion electrical signal of the magnetic bead 201.
测量线圈220将其检测获得的磁珠201的运动电信号传送至处理器。可选地,该测量线圈220可以通过信号转换电路(未示出)和信号调理电路(未示出)连接至处理器。例如,信号转换电路能够对测量线圈220获取的磁珠201在至少一段持续时间内的运动电信号进行模数转换,信号调理电路能够对测量线圈220获取的磁珠201在至少一段持续时间内的运动电信号进行整流、滤波及归一化等预处理。图3b为一个实施例中该磁珠201在一段持续时间内的运动电信号的示意图,其中,该磁珠201的运动电信号可以为电压信号,在本实施例中,磁珠201在反应容器200内做往复运动,该磁珠201在一段持续时间内的运动电信号呈类似正弦分布,如图中所示。The measurement coil 220 transmits the motion electric signal of the magnetic bead 201 obtained by the detection to the processor. Alternatively, the measurement coil 220 may be connected to the processor through a signal conversion circuit (not shown) and a signal conditioning circuit (not shown). For example, the signal conversion circuit can perform analog-to-digital conversion on the motion electrical signal of the magnetic bead 201 acquired by the measuring coil 220 for at least a period of time, and the signal conditioning circuit can be capable of converting the magnetic bead 201 acquired by the measurement coil 220 for at least a period of time. The motion electric signal is preprocessed such as rectification, filtering and normalization. FIG. 3b is a schematic diagram of the movement electrical signal of the magnetic bead 201 in a period of time in an embodiment, wherein the movement electrical signal of the magnetic bead 201 may be a voltage signal. In this embodiment, the magnetic bead 201 is in the reaction vessel Reciprocating motion within 200, the electric signal of the magnetic bead 201 in a period of time presents a sinusoidal distribution, as shown in the figure.
光学法检测装置18用于在处理器19的控制下对由被测样本和试剂混合后的试样(被测物)基于光学法进行凝血项目检测,并输出反映凝固情况的电信号至处理器19。基于光学法对试样进行凝血项目检测的区域称为光学法检测区域。The optical method detection device 18 is used to detect the coagulation item based on the optical method of the sample (analyte) mixed with the test sample and the reagent under the control of the processor 19, and output an electrical signal reflecting the coagulation condition to the processor 19. The area where the sample is tested for coagulation based on the optical method is called the optical detection area.
一种实施例中,光学法检测装置400的结构如图4所示,可以包括进行光学法检测的光源410、透镜组件420、滤光器430和接收单元450。在本申请中,光源410可以采用卤素灯,优选的,将卤素灯收纳于有多个散热片的灯盒内,散热片用于冷却光源410发热而产生的热气。透镜组件420由多个聚光镜组成,用于将光源410发出的散射光进行会聚和准直。透镜组件420配置于将光源410照射的光线导向试样440(被测物)的光路上。In an embodiment, the structure of the optical method detection device 400 is shown in FIG. 4, and may include a light source 410 for performing optical method detection, a lens assembly 420, a filter 430 and a receiving unit 450. In the present application, a halogen lamp may be used as the light source 410. Preferably, the halogen lamp is accommodated in a lamp case having a plurality of heat sinks. The heat sinks are used to cool the heat generated by the light source 410 due to heat generation. The lens assembly 420 is composed of a plurality of condensers, and is used to converge and collimate the scattered light emitted by the light source 410. The lens assembly 420 is disposed on the optical path that guides the light irradiated by the light source 410 to the sample 440 (object to be measured).
在本申请实施例中,滤光器430可以为圆盘形、多边形等,在优选的实施例中,滤光器430为圆盘形,其可以在电机的驱动下以圆心为轴做中心旋转。滤光器430上设有多个孔,在本申请的一个实施例中以滤光器430上设有6个孔为例进行说明,其他情况可参照本实施例有相同或类似的应用。如图所示,孔431为堵塞不透光的孔,其余5个孔432用于安装5种透射波长各不相同的滤光片,例如,5个滤光片分别只透射340nm、405nm、575nm、660nm和800nm的光,其他波长的光不透射,孔431可以为备用孔,需要追加光学膜时才安装光学膜。6个孔以一定的角度间隔沿滤光器430的旋转方向而设,随着滤光器430的转动,滤光片可被旋转到光路上,以使光经滤光片后只有与滤光片波长匹配的光才能通过并照射在后面的反应容器上,以进行光学检测。In the embodiment of the present application, the filter 430 may be a disc shape, a polygon, etc. In a preferred embodiment, the filter 430 is a disc shape, which can be rotated around the center of the circle under the drive of a motor . The filter 430 is provided with a plurality of holes. In one embodiment of the present application, six holes are provided on the filter 430 as an example for description. For other cases, refer to this embodiment for the same or similar applications. As shown in the figure, the hole 431 is a hole to block the opaque light, and the remaining five holes 432 are used to install five filters with different transmission wavelengths. For example, the five filters only transmit 340nm, 405nm, and 575nm, respectively , 660nm and 800nm light, other wavelengths of light are not transmitted, the hole 431 can be a spare hole, only need to add an optical film before installing the optical film. The 6 holes are provided along the rotation direction of the filter 430 at a certain angular interval. With the rotation of the filter 430, the filter can be rotated to the optical path, so that the light only passes through the filter after passing through the filter Only the light with the matching wavelength of the film can pass through and illuminate the reaction container behind for optical detection.
在基于光学法对反应容器中的试样进行凝血项目检测时,不同的凝血项目需要特定波长的光照射,例如凝血酶原时间(PT)检测项目需要的是405nm波长的光照射试样,因此处理器控制电机将滤光器430上的405nm波长的滤光片旋转到光路上。凝血酶时间(TT)检测项目需要的是660nm波长的光照射试样,因此处理器控制电机将滤光器430上的660nm波长的滤光片旋转到光路上。When performing the coagulation test on the sample in the reaction container based on the optical method, different coagulation items require light irradiation of a specific wavelength. For example, the prothrombin time (PT) test item requires 405nm wavelength light to illuminate the sample, so The processor controls the motor to rotate the 405 nm wavelength filter on the filter 430 onto the optical path. The thrombin time (TT) test item requires 660nm wavelength light to illuminate the sample, so the processor controls the motor to rotate the 660nm wavelength filter on the filter 430 to the optical path.
接收单元450连接至处理器,接收单元450用于收集试样被特定波长的光照射后的透射光和/或散射光,并将光信号转换成电信号,将电信号传送至处理器。处理器对电信号进行处理后得到被测血样的测量参数。The receiving unit 450 is connected to the processor. The receiving unit 450 is used to collect transmitted light and/or scattered light after the sample is irradiated with light of a specific wavelength, convert the optical signal into an electrical signal, and transmit the electrical signal to the processor. After the processor processes the electrical signal, the measurement parameters of the blood sample to be measured are obtained.
当然在其他的实施例中,光学法检测装置400也可以不采用上述卤素灯的方案,而是采用多个波长的LED,通过与LED对应的二向色镜将多个LED发出的光束合束,或者采用合光棱镜进行多个波长光束的合束,即不对光学法检测装置400的检测结构或检测方式进行限定,在此不再赘述。Of course, in other embodiments, the optical method detection device 400 may not use the above halogen lamp solution, but adopt LEDs with multiple wavelengths, and combine the beams emitted by the multiple LEDs through a dichroic mirror corresponding to the LEDs. Or, a light combining prism is used to combine multiple wavelength beams, that is, the detection structure or detection method of the optical method detection device 400 is not limited, and details are not described herein again.
如图5所示为一种示例性的血红蛋白、胆红素、乳糜等干扰物的光谱曲线图,横轴为波长(单位nm),纵轴为吸光度,发明人注意到,三种物质在不同的波长处具有不同的吸光度,反应了三种干扰物对不同波长的光具有不同的吸收能力,特别是乳糜,其在可见光范围340nm-790nm之间都具有吸光度,意味着当被测物中含有大量乳糜时,用可见光对被测物进行照射将有大量的光被乳糜吸收,从而影响基于光学法的凝血检测结果。As shown in Fig. 5 is an exemplary hemoglobin, bilirubin, chyle and other interfering substances spectral curve, the horizontal axis is the wavelength (unit nm), the vertical axis is the absorbance, the inventor noticed that the three substances are different The wavelength has different absorbances, reflecting that the three interferences have different absorption capabilities for light of different wavelengths, especially chyle, which has absorbance in the visible range of 340nm-790nm, which means that when the object contains When there is a large amount of chyle, irradiating the test object with visible light will absorb a large amount of light by the chyle, which will affect the results of coagulation detection based on the optical method.
因此本发明实施例中在进行正式凝血项目检测前增加预判环节,判断被测样本中是否含有会对基于光学法的凝血检测结果具有影响的干扰物。Therefore, in the embodiment of the present invention, a pre-judgment link is added before the formal coagulation test is performed to determine whether the sample to be tested contains an interferer that has an effect on the coagulation detection result based on the optical method.
本实施例中,预判装置16用于在处理器19的控制下对被测物在进行凝血检测之前先进行光学检测,得到光学检测结果。预判装置16检测的被测物中至少包含有被测样本,即被测物可以是血浆,或者是血浆和试剂的混合物(试样),试剂包括稀释液、混合试剂和触发试剂中的至少一种。预判装置16对被测物进行光学检测的检测位置可以是专用位置,也可以是孵育区域、光学法检测区域或磁珠法检测区域。In this embodiment, the pre-judgment device 16 is used to perform optical detection on the test object before performing coagulation detection under the control of the processor 19 to obtain an optical detection result. The test object detected by the pre-judgment device 16 contains at least the test sample, that is, the test object may be plasma, or a mixture of plasma and reagent (sample), and the reagent includes at least the diluent, mixed reagent, and trigger reagent. One kind. The detection position where the pre-judgment device 16 optically detects the object may be a dedicated position, or may be an incubation area, an optical method detection area, or a magnetic bead method detection area.
在本申请的一实施例中,预判装置16包括光电检测装置,光电检测装置包括光发射端和光接收端,其中,光发射端用于采用至少一种特定波长的光或波长与特定波长接近的光对被测物进行照射,特定波长是指在采用光学法对试样进行凝血项目检测时用到的光波长。光接收端用于检测被测物经光作用后的光的光学信息,得到被测物针对各特定波长光的光学检测结果。光学信息可以为光束通过被测物后的透射和/或散射光强。光接收端与处理器19信号连接,用于将得到的光学检测结果发送至处理器19。In an embodiment of the present application, the pre-judgment device 16 includes a photodetection device, and the photodetection device includes a light emitting end and a light receiving end, wherein the light emitting end is used to adopt at least one kind of specific wavelength light or the wavelength is close to the specific wavelength The specific light refers to the wavelength of light used when the coagulation item is detected by the optical method. The light receiving end is used to detect the optical information of the light of the test object after being subjected to light, to obtain the optical detection result of the test object for light of each specific wavelength. The optical information may be the transmitted and/or scattered light intensity after the light beam passes through the measured object. The light receiving end is signally connected to the processor 19, and is used to send the obtained optical detection result to the processor 19.
在有的实施例中,预判装置16的光发射端与光学法检测装置相连,其对被测物进行照射的光束为经过滤光器430滤光后通过光纤分出的光线;当预判装置16对被测物进行光学检测的检测位置为光学法检测区域时,可以直接用相应透光性的滤光器430滤光后的光线对被测物进行照射,不需要单独光源。在有的实施例中,预判装置16的光发射端也可有单独的光源。In some embodiments, the light emitting end of the pre-judgment device 16 is connected to the optical method detection device, and the light beam that irradiates the object to be measured is the light beam that is filtered by the filter 430 and then split through the optical fiber; when the pre-judgment When the detection position where the device 16 optically detects the object is the optical detection area, the light filtered by the corresponding light-transmitting filter 430 can be directly irradiated to the object without a separate light source. In some embodiments, the light emitting end of the pre-judgment device 16 may also have a separate light source.
在本申请的另一实施例中,预判装置16包括图像采集装置,图像采集装置用于采集被测物的图像数据(例如照片),得到光学检测结果,并将光学检测结果发送至处理器19。在具体实施例中,图像采集装置可以为用于拍摄图像数据的摄像头。In another embodiment of the present application, the pre-judgment device 16 includes an image acquisition device, the image acquisition device is used to collect image data (such as photos) of the object to be measured, to obtain an optical detection result, and send the optical detection result to the processor 19. In a specific embodiment, the image acquisition device may be a camera for capturing image data.
处理器19用于获取反映被测血样中干扰物情况的干扰物信息,根据干扰物信息判断是由光学法检测装置对被测物进行凝血检测还是由磁珠法检测装置对被测物进行凝血检测,并接收反映凝固情况的电信号,对电信号进行处理后得到被测血样的测量参数,其中,干扰物是指对基于光学法的凝血检测有影响的物质。The processor 19 is used to obtain the interference information reflecting the condition of the interference in the blood sample to be tested, and to determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device performs coagulation on the test object based on the interference information Detect and receive the electrical signal reflecting the coagulation situation, and then process the electrical signal to obtain the measurement parameters of the blood sample to be measured. Among them, the interfering substance refers to the substance that has an influence on the coagulation detection based on the optical method.
在本申请的一实施例中,处理器19根据光学检测结果得到反映被测物中干扰物情况的干扰物信息,例如,预判装置16的光发射端采用至少一种特定波长的光照射被测物,光接收端接收被测物经光照射后的透射光和/或散射光,处理器19根据从预判装置16的光接收端接收到的光学信息计算被测物针对各特定波长光的吸光度值,在至少有一种特定波长光的吸光度值大于预设阈值时,说明试样会对特定波长光有吸收,判断被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响。其中,预设阈值针对不同的特定波长光具有不同的数值,其可为系统默认设定值,也可以为用户根据经验或实验数据而设定的值。在本实施例中,当被测物中的干扰物不会对基于光学法的凝血检测项目的检测结果有影响时,或者说被测物中不存在对基于光学法的凝血检测项目的检测结果产生影响的干扰物时,处理器控制光学法检测装置对被测物基于光学法进行凝血检测;当被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响时,或者说被测物中存在对基于光学法的凝血检测项目的检测结果产生影响的干扰物时,处理器控制磁珠法检测装置对被测物基于磁珠法进行凝血检测。干扰物是指吸收特定波长光的物质,其中,特定波长是指采用光学法对血浆和试剂的混合试样进行凝血检测时使用的光波长中的至少一种。In an embodiment of the present application, the processor 19 obtains interference information reflecting the condition of the interference in the test object according to the optical detection result. For example, the light emitting end of the pre-judgment device 16 is irradiated with light of at least one specific wavelength The test object, the light receiving end receives the transmitted light and/or scattered light of the test object after being irradiated with light, and the processor 19 calculates the test object for each specific wavelength of light based on the optical information received from the light receiving end of the pre-judgment device 16 When the absorbance value of at least one specific wavelength light is greater than the preset threshold value, it means that the sample will absorb the specific wavelength light, and the interference in the test object will be detected by the optical method for the detection of blood coagulation. The results have an impact. Wherein, the preset threshold has different values for different specific wavelengths of light, which may be the system default setting value, or a value set by the user based on experience or experimental data. In this embodiment, when the interference in the test object does not affect the detection result of the coagulation test item based on the optical method, or the test result of the coagulation test item based on the optical method does not exist in the test object When an interferer is affected, the processor controls the optical method detection device to perform coagulation detection on the object based on the optical method; when the interference in the object will affect the detection result of the coagulation detection item based on the optical method, or When it is said that there is an interfering substance that affects the detection result of the coagulation detection item based on the optical method, the processor controls the magnetic bead method detection device to perform coagulation detection on the object based on the magnetic bead method. The interfering substance refers to a substance that absorbs light of a specific wavelength, wherein the specific wavelength refers to at least one of the wavelengths of light used when performing coagulation detection on a mixed sample of plasma and reagent by an optical method.
在另外的实施例中,也可以采用与特定波长相接近的光照射被测物,同样也可以判断被测物中是否存在对基于光学法的凝血检测项目的检测结果将产生影响的干扰物。In another embodiment, the test object may be irradiated with light close to a specific wavelength, and it may also be determined whether there is an interfering substance that will affect the detection result of the coagulation test item based on the optical method.
在本申请的另一实施例中,处理器19根据从预判装置16接收到的图像数据(例如照片)识别被测物的颜色,将被测物的颜色和预设颜色比较,在被测物的颜色和预设颜色相同或相近时,判断被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响。其中,预设颜色为被测物中无干扰物时获取图像数据的颜色,其可为系统默认设定颜色,也可以为用户根据经验或实验数据而设定的颜色。在本实施例中,当被测物中的干扰物不会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制光学法检测装置对被测物进行凝血检测;当被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制磁珠法检测装置对被测物进行凝血检测。In another embodiment of the present application, the processor 19 recognizes the color of the test object based on the image data (such as a photo) received from the pre-judgment device 16 and compares the color of the test object with the preset color. When the color of the object is the same as or close to the preset color, it is judged that the interference in the object will affect the detection result of the blood coagulation detection item based on the optical method. Among them, the preset color is the color of the image data obtained when there is no interference in the test object, which can be the default color set by the system or the color set by the user based on experience or experimental data. In this embodiment, when the interference in the test object does not affect the detection result of the coagulation detection item based on the optical method, the processor controls the optical method detection device to perform coagulation detection on the test object; when the test object When the interfering substance in the test will affect the detection result of the coagulation detection item based on the optical method, the processor controls the magnetic bead method detection device to perform coagulation detection on the test object.
在有的实施例中,如图6所示,基于光学法进行凝血检测的光学法检测区域和基于磁珠法进行凝血检测的磁珠法检测区域是同一检测区域。用于磁珠法进行凝血检测的反应容器与用光学法进行凝血检测的盛放试样的容器为同一装置。应用磁珠法进行检测时,需要在反应容器的底部放置磁珠,当用磁珠法进行凝血检测时,磁珠在驱动线圈的驱动下移动,测量线圈根据生成的感应电磁场获得由于磁珠运动而产生的运动电信号,并将电信号发送至处理器;当用光学法进行凝血检测时,反应容器无需放置磁珠,发射光纤采用至少一种特定波长光或波长与特定波长接近的光对反应容器中的被测物进行照射,接收光纤将接收到的光线信息传送至光电转换单元处理得到电信号。可以在应用磁珠法进行检测时磁珠才被放置在反应容器,而在应用光学法进行检测时反应容器中没有磁珠,这种情况下,凝血分析仪还包括用于取放磁珠的取放装置;当然在一些实施例中,磁珠可以一直放置在反应容器中,进行光学法检测时,磁珠将一直静止在反应容器底部,这种情况下,凝血分析仪无需用于取放磁珠的取放装置。In some embodiments, as shown in FIG. 6, the optical detection area based on the optical method for coagulation detection and the magnetic bead detection area based on the magnetic bead method are the same detection area. The reaction container used for the magnetic bead method for coagulation detection is the same device as the container for holding the sample which is used for the optical method for coagulation detection. When the magnetic bead method is used for detection, the magnetic beads need to be placed at the bottom of the reaction vessel. When the magnetic bead method is used for coagulation detection, the magnetic beads move under the drive of the driving coil, and the measurement coil obtains the movement of the magnetic beads according to the generated induced electromagnetic field. The generated electrical signals are sent to the processor; when using the optical method for coagulation detection, there is no need to place magnetic beads in the reaction vessel, and the emission fiber uses at least one light of a specific wavelength or a light pair with a wavelength close to a specific wavelength The test object in the reaction vessel is irradiated, and the receiving optical fiber transmits the received light information to the photoelectric conversion unit to obtain an electric signal. The magnetic beads can only be placed in the reaction container when the magnetic bead method is used for detection, and there are no magnetic beads in the reaction container when the optical method is used for detection. In this case, the coagulation analyzer also includes Pick-and-place device; of course, in some embodiments, the magnetic beads can always be placed in the reaction vessel. When performing optical detection, the magnetic beads will always remain at the bottom of the reaction vessel. In this case, the coagulation analyzer does not need to be used for pick-and-place Magnetic bead pick and place device.
如图7所示,在有的实施例中,该分析仪也可以同时设置多个如图6所示的检测区域,用于对多个样本同时进行检测,各检测区域可以共用一个光学照射单元,通过分光器将光束引向各个检测区域以对各被测物进行照射。若预判装置对被测物进行光学检测的位置不是该区域,还可以通过分光器将光束引向光学检测的位置(例如,专用位置、孵育区域等)。As shown in FIG. 7, in some embodiments, the analyzer may also be provided with multiple detection areas as shown in FIG. 6 for detecting multiple samples at the same time, and each detection area may share an optical irradiation unit , The beam is directed to each detection area by a beam splitter to illuminate each object to be measured. If the position where the pre-judgment device performs optical detection on the object is not in this area, the beam can also be directed to the optical detection position (for example, dedicated position, incubation area, etc.) through the beam splitter.
在本申请的另外的实施例中,凝血分析仪也可以不包括预判装置,而对被测样本的预判结果可以来自于联机的其他模块,也即获取反映被测血样中干扰物情况的干扰物信息可以来自联机的其他仪器,无需在凝血分析仪本机设置预判装置。或者直接使磁珠法检测装置和光学法检测装置共用同一检测区域;被测物转运机构在处理器的控制下将容纳有被测物的反应容器转运到共用检测区域;处理器控制先由光学法检测装置对被测物进行凝血检测,在光学法检测装置检测不准确或不能输出反映凝固情况的电信号时,再由磁珠法检测装置对被测物进行凝血检测。In another embodiment of the present application, the coagulation analyzer may not include a pre-judgment device, and the pre-judgment result of the sample to be tested may come from other modules connected online, that is, to obtain information reflecting the condition of interfering substances in the blood sample to be tested. The information of interfering substances can come from other on-line instruments, and there is no need to install a pre-judgment device on the coagulation analyzer. Or directly make the magnetic bead method detection device and the optical method detection device share the same detection area; the analyte transport mechanism transports the reaction container containing the analyte to the common detection area under the control of the processor; the processor controls the optical The method detection device performs coagulation detection on the test object. When the optical method detection device detects inaccuracy or fails to output an electrical signal reflecting coagulation, the magnetic bead method detection device performs coagulation detection on the test object.
本申请上述实施例中的凝血分析仪主要用于对被测物进行凝血分析,与现有技术不同之处在于,本申请中的凝血分析仪既可以基于光学法采用光学法检测装置对被测物进行凝血检测,又可以基于磁珠法采用磁珠法检测装置对被测物进行凝血检测。并且由于光学法能够输出测试过程中的光学信息曲线,从而对结果和仪器状态能够给出相对于磁珠法更多有价值的判断,故在实际应用中优选光学法。但是,当被测样本中存在大量吸收特定波长的干扰物时,采用磁珠法进行凝血项目检测,可避免干扰物对基于光学法的凝血检测结果的影响。The blood coagulation analyzer in the above embodiments of the present application is mainly used for performing blood coagulation analysis on the test object. The difference from the prior art is that the blood coagulation analyzer in the present application can use an optical method detection device to measure the object based on the optical method. For the coagulation detection of the substance, the magnetic bead method detection device can be used for the coagulation detection of the analyte based on the magnetic bead method. And because the optical method can output the optical information curve in the test process, so that the result and the state of the instrument can be given more valuable judgment than the magnetic bead method, so the optical method is preferred in practical applications. However, when there are a large number of interfering substances that absorb specific wavelengths in the tested sample, the magnetic bead method is used to detect the coagulation item, which can avoid the influence of the interfering substances on the coagulation detection results based on the optical method.
请参考图8,对被测物先进行预判再进行凝血分析的血样分析方法包括如下步骤:Please refer to Fig. 8, the blood sample analysis method of pre-judging the test object and then performing coagulation analysis includes the following steps:
步骤801,启动凝血分析仪血样分析程序。Step 801: Start the blood sample analysis program of the coagulation analyzer.
步骤802,获取对被测血样进行检测的项目,判断检测项目是否为凝固法项目,若检测项目是凝固法项目执行步骤803,若检测项目不是凝固法项目则执行步骤807,选择其他方法对被测物进行检测并输出检测结果。Step 802: Obtain the test item for the blood sample to be tested, and determine whether the test item is a coagulation method item. If the test item is a coagulation method item, perform step 803. If the test item is not a coagulation method item, perform step 807. Select another method. The test object is tested and the test result is output.
步骤803,对盛装在反应容器中的被测物进行光学检测,得到光学检测结果,并根据光学检测结果得到反映被测物中干扰物情况的干扰物信息。根据被测血样的凝血检测项目,可得知后续采用光学法进行凝血项目检测时用到的特定波长,在优选的实施例中,采用特定波长一一对盛装在反应容器中的被测物进行光照射,并收集被测物经光照射后的透射光和/或散射光。其中,被测物中至少包含有被测血样的血浆,本步骤中的被测物可以是血浆,也可以是血浆和试剂的混合物。Step 803: Perform optical detection on the test object contained in the reaction container to obtain an optical detection result, and obtain interference information reflecting the situation of the interference in the test object according to the optical detection result. According to the coagulation test item of the blood sample to be tested, the specific wavelength used in the subsequent coagulation item test using the optical method can be known. In a preferred embodiment, the specific wavelength is used one by one to the test objects contained in the reaction vessel Light irradiation, and collect the transmitted light and/or scattered light of the test object after light irradiation. Among them, the test object contains at least the plasma of the blood sample to be tested, and the test object in this step may be plasma or a mixture of plasma and reagent.
根据血液凝固的瀑布效应理论,被测样本与稀释液和/或混合试剂混合后,以及在刚加入触发试剂的一段时间内,主要是凝血因子的级联反应,而没有形成纤维蛋白结合的纤维蛋白多聚体,此时级联反应引起的吸光度变化很小。因此,如果分析这段时间,就可以得到基本准确的样本的吸光度数据,从而可以判断干扰物情况。According to the waterfall effect theory of blood coagulation, after the test sample is mixed with the diluent and/or mixed reagent, and within a period of time just after the trigger reagent is added, it is mainly a cascade reaction of coagulation factors, but no fibrin-bound fibers are formed For protein multimers, the absorbance caused by the cascade reaction changes little at this time. Therefore, if this period of time is analyzed, the absorbance data of the sample can be obtained substantially accurately, so that the condition of the interfering substance can be judged.
例如,对于被测样本加入了触发试剂后一小段时间内有明显光通量的基线期的凝血检测项目,如一些基于凝固法的检测项目等,会形成一个较明显的光通量基线期。在光通量基线期,被测物发生凝血因子的级联反应,因此其光通量变化很小,光通量曲线平缓。在该光通量基线期,检测到的吸光度数据只是被测样本吸光度数据和试剂吸光度数据的叠加。由于试剂吸光度数据是已知的,因此可以得到被测样本的吸光度数据,从而可以判断干扰物情况。 For example, for a coagulation test item with a significant luminous flux baseline period within a short period of time after the test sample is added with the trigger reagent, such as some coagulation-based testing items, a more obvious luminous flux baseline period will be formed. During the baseline period of luminous flux, the analyte undergoes a cascade of coagulation factors, so its luminous flux changes little and the luminous flux curve is flat. In this baseline period of luminous flux, the detected absorbance data is only the superposition of the absorbance data of the sample and the reagent absorbance data. Since the reagent absorbance data is known, the absorbance data of the sample to be tested can be obtained, so that the interference can be determined.
又例如,对于被测样本加入了稀释液、混合试剂后一段时间内(加入触发试剂之前),检测样本的光通量基本无变化的项目,在加入触发试剂之前检测样本的吸光度数据只是被测样本与稀释液、混合试剂吸光度数据的叠加。由于稀释液和混合试剂吸光度数据是已知的,因此可以得到被测样本的吸光度数据,从而可以判断干扰物情况。For another example, for a period of time after the test sample is added with diluent and mixed reagents (before the trigger reagent is added), the luminous flux of the test sample is basically unchanged. The absorbance data of the test sample before the trigger reagent is added is only the test sample and Superimposition of absorbance data of diluent and mixed reagent. Since the absorbance data of the diluent and mixed reagents are known, the absorbance data of the tested sample can be obtained, so that the condition of the interfering substances can be judged.
通常,先加入稀释液和混合试剂,然后再加入触发试剂。在某些凝血检测项目可能不需要加入稀释液和混合试剂。Generally, the diluent and mixed reagent are added first, followed by the trigger reagent. In some coagulation tests, it may not be necessary to add diluent and mixed reagents.
请参考图9,本实施例中对被测物进行光学检测的过程包括如下步骤901-步骤903:Please refer to FIG. 9, the process of optical detection of the measured object in this embodiment includes the following steps 901-903:
步骤901,采用至少一种波长的光对被测物进行照射。在向被测样本加入试剂得到被测物后的设定时长内,采用特定波长的光照射被测物,获取光束照射被测物后的散射光和/或透射光的光学信息。其中,设定时长为根据向被测样本中加入的试剂种类和加入试剂的时间而设定。这里光束来自光学法检测装置,在另外的实施例中,也可以为预判装置独有的光源。Step 901: Irradiate the test object with light of at least one wavelength. Within a set time period after adding the reagent to the sample to obtain the sample, the sample is irradiated with light of a specific wavelength to obtain optical information of scattered light and/or transmitted light after the beam irradiates the sample. Among them, the setting time is set according to the type of reagent added to the sample to be tested and the time of adding the reagent. Here, the light beam comes from the optical method detection device. In another embodiment, it may also be a light source unique to the prediction device.
 步骤902,检测所述被测物经光作用后的光学信息。光学信息包括被测物的吸光度信息,该吸光度信息主要是被测样本的吸光度数据和试剂的吸光度数据的叠加,如果从检测样本的吸光度信息中减去试剂本身的吸光度数据,就可以得到被测样本的吸光度数据。通常,预判装置检测的是光通量数据,此处光通量数据包括透射光和/或散射光的光通量数据,然后根据该光通量数据和光源的初始光通量确定吸光度信息,即可根据该光通量数据得到吸光度信息。因此,光学信息还可以包括光束照射被测物后的散射光和/或透射光的光通量数据。 Step 902: Detect the optical information of the test object after being subjected to light. The optical information includes the absorbance information of the test object. The absorbance information is mainly the superposition of the absorbance data of the test sample and the absorbance data of the reagent. If the absorbance data of the reagent itself is subtracted from the absorbance information of the test sample, the measured value can be obtained. The absorbance data of the sample. Generally, the pre-judgment device detects the luminous flux data, where the luminous flux data includes the luminous flux data of the transmitted light and/or scattered light, and then the absorbance information is determined according to the luminous flux data and the initial luminous flux of the light source, and the absorbance information can be obtained according to the luminous flux data . Therefore, the optical information may also include luminous flux data of scattered light and/or transmitted light after the light beam illuminates the object.
由于乳糜、血红蛋白、胆红素等干扰物有各自的吸收光谱,因此可以用多个不同波长的光束照射该被测物,通过每个波长的光束照射后,根据被测物的吸光度值来判断对应的干扰物的情况,例如是否含有干扰物。例如可以应用多种波长的光束照射被测物,各个波长的光束分别对应乳糜、血红蛋白、胆红素三种干扰物,从而可以根据各个波长光束的吸光度值来判断对应的干扰物情况。因此,在其中一种实施例中,应用多于一种波长的光束照射被测物。Because interfering substances such as chyle, hemoglobin, and bilirubin have their own absorption spectra, they can be irradiated with multiple beams of different wavelengths. After irradiated with beams of each wavelength, they can be judged according to the absorbance value of the measured substance. The situation of the corresponding interference, for example, whether it contains interference. For example, light beams of various wavelengths can be used to irradiate the object to be measured, and the light beams of each wavelength correspond to three kinds of interfering substances, such as chyle, hemoglobin, and bilirubin, so that the corresponding interfering substances can be judged according to the absorbance values of the light beams of each wavelength. Therefore, in one of the embodiments, more than one wavelength beam is used to illuminate the object.
步骤903,根据光学信息得到被测物的光学检测结果。根据光学信息计算被测物针对各特定波长光的吸光度值,当吸光度值大于预设阈值时,判断被测物中的干扰物会对基于光学法的凝血检测项目有影响。其中,预设阈值为根据预知的试剂的吸光度信息、预知的没干扰物情况下被测样本的吸光度信息、以及预知的被测样本和试剂的比例信息得到。试剂的吸光度信息,以及被测样本和试剂的比例信息都是可以从仪器的设置信息或检测参数中获取的,因此是预知的。比例信息可以是容积比例信息或重量比例信息。 Step 903: Obtain the optical detection result of the test object according to the optical information. According to the optical information, the absorbance value of the test object for each specific wavelength of light is calculated. When the absorbance value is greater than the preset threshold, it is judged that the interference in the test object will affect the coagulation detection item based on the optical method. Wherein, the preset threshold value is obtained based on the predicted absorbance information of the reagent, the predicted absorbance information of the measured sample without interference, and the predicted ratio information of the tested sample and the reagent. The absorbance information of the reagent and the ratio information of the sample to be tested and the reagent can be obtained from the setting information or detection parameters of the instrument, so it is foreseeable. The ratio information may be volume ratio information or weight ratio information.
在有的实施例中,光学检测还包括:采集被测物的图像数据(例如照片),根据图像数据得到颜色信息,根据颜色信息得到反映被测物中干扰物情况的干扰物信息,以得到光学检测结果。In some embodiments, the optical detection further includes: collecting image data (such as a photo) of the measured object, obtaining color information based on the image data, and obtaining interference information reflecting the condition of the interference in the measured object according to the color information to obtain Optical inspection results.
在有的实施例中,在得到干扰物信息后,还可以根据被测样本中的干扰物情况发出提示信息和/或警报信息,例如,提示信息和/或警报信息可以包括:关于被测样本中的干扰物情况的提示信息和/或警报信息、或者确定采用光学法或磁珠法的提示信息。In some embodiments, after obtaining the interference information, the prompt information and/or the alarm information may also be issued according to the interference in the tested sample. For example, the prompt information and/or the alarm information may include: Prompt information and/or warning information of the interference in the system, or prompt information that determines to use the optical method or the magnetic bead method.
步骤803之后,可以执行步骤804。After step 803, step 804 may be performed.
步骤804,根据干扰物信息判断是否会对基于光学法的凝血检测项目的检测结果有影响,确定对被测血样采用的凝血检测方法,当被测物中的干扰物不会对基于光学法的凝血检测项目的检测结果有影响时执行步骤806,当被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响时,执行步骤805。Step 804: According to the interference information, determine whether it will affect the detection result of the coagulation detection item based on the optical method, and determine the coagulation detection method used for the blood sample to be tested. When the interference in the sample does not affect the detection method based on the optical method Step 806 is executed when the detection result of the coagulation detection item has an influence, and step 805 is executed when the interference in the test object has an influence on the detection result of the coagulation detection item based on the optical method.
步骤805, 处理器控制磁珠法检测装置对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号,并对电信号进行处理以得到被测血样的测量参数。Step 805: The processor controls the magnetic bead method detection device to perform coagulation detection on the test object based on the magnetic bead method, output an electrical signal reflecting the coagulation status, and process the electrical signal to obtain the measurement parameters of the blood sample to be measured.
步骤806,处理器控制光学法检测装置对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号,并对电信号进行处理以得到被测血样的测量参数。Step 806: The processor controls the optical method detection device to perform coagulation detection on the test object based on the optical method, output an electrical signal reflecting the coagulation status, and process the electrical signal to obtain the measurement parameters of the blood sample to be measured.
在另一实施例中,在确定检测项目是凝固项目时,还可以不采用步骤803的方法对被测物进行光学检测,而直接用光学法检测装置对被测物进行凝血检测,在光学法检测装置检测不准确或不能输出反映凝固情况的电信号时,再用磁珠法检测装置对被测物进行凝血检测。In another embodiment, when it is determined that the detection item is a coagulation item, the method of step 803 may not be used for optical detection of the test object, but the optical method detection device may be used for direct detection of the blood coagulation of the test object. When the detection device detects inaccuracy or fails to output an electrical signal reflecting the coagulation situation, the magnetic bead method detection device is then used to detect the coagulation of the test object.
本申请还提供一实施方式的凝血分析仪,其用于测定并分析与血液凝固/纤溶功能有关的特定物质数量及其活性程度,标本为血浆。本实施方式的凝血分析仪用凝固时间法、发色底物法和免疫比浊法对标本进行测定。本实施方式所用的凝固时间法是一种将标本凝固过程作为透射光的变化检测或磁珠在磁力驱动下于标本内运动变化检测的测定方法。凝固时间法的测定项目有PT(凝血酶原时间)、APTT(活化部分凝血酶时间)、TT(凝血酶时间)和FIB(纤维蛋白原量)等。发色底物法的测定项目有AT-Ⅲ(抗凝血酶Ⅲ)等,免疫比浊法的测定项目有D-Dimer(D-二聚体)和FDP等。The present application also provides a coagulation analyzer according to an embodiment, which is used to measure and analyze the number of specific substances related to blood coagulation/fibrinolysis function and the degree of activity thereof, and the specimen is plasma. The coagulation analyzer of the present embodiment measures the specimen by the clotting time method, the chromogenic substrate method, and the immunoturbidimetric method. The coagulation time method used in this embodiment is a measurement method that uses the coagulation process of a specimen as a change in transmitted light detection or a motion change of a magnetic bead in a specimen driven by a magnetic force. The measurement items of the clotting time method include PT (prothrombin time), APTT (activated partial thrombin time), TT (thrombin time), and FIB (fibrinogen amount). The measurement items of the chromogenic substrate method include AT-Ⅲ (antithrombin III), etc., and the measurement items of the immunoturbidimetric method include D-Dimer (D-dimer) and FDP.
本文参照了各种示范实施例进行说明。然而,本领域的技术人员将认识到,在不脱离本文范围的情况下,可以对示范性实施例做出改变和修正。例如,各种操作步骤以及用于执行操作步骤的组件,可以根据特定的应用或考虑与系统的操作相关联的任何数量的成本函数以不同的方式实现(例如一个或多个步骤可以被删除、修改或结合到其他步骤中)。This document refers to various exemplary embodiments. However, those skilled in the art will recognize that changes and modifications can be made to the exemplary embodiments without departing from the scope of this document. For example, various operation steps and components for performing operation steps may be implemented in different ways according to a specific application or considering any number of cost functions associated with the operation of the system (for example, one or more steps may be deleted, Modify or incorporate into other steps).
另外,如本领域技术人员所理解的,本文的原理可以反映在计算机可读存储介质上的计算机程序产品中,该可读存储介质预装有计算机可读程序代码。任何有形的、非暂时性的计算机可读存储介质皆可被使用,包括磁存储设备(硬盘、软盘等)、光学存储设备(CD-ROM、DVD、Blu Ray盘等)、闪存和/或诸如此类。这些计算机程序指令可被加载到通用计算机、专用计算机或其他可编程数据处理设备上以形成机器,使得这些在计算机上或其他可编程数据处理装置上执行的指令可以生成实现指定的功能的装置。这些计算机程序指令也可以存储在计算机可读存储器中,该计算机可读存储器可以指示计算机或其他可编程数据处理设备以特定的方式运行,这样存储在计算机可读存储器中的指令就可以形成一件制造品,包括实现指定功能的实现装置。计算机程序指令也可以加载到计算机或其他可编程数据处理设备上,从而在计算机或其他可编程设备上执行一系列操作步骤以产生一个计算机实现的进程,使得在计算机或其他可编程设备上执行的指令可以提供用于实现指定功能的步骤。In addition, as understood by those skilled in the art, the principles herein may be reflected in a computer program product on a computer-readable storage medium that is pre-installed with computer-readable program code. Any tangible, non-transitory computer-readable storage medium can be used, including magnetic storage devices (hard disks, floppy disks, etc.), optical storage devices (CD-ROM, DVD, Blu Ray disks, etc.), flash memory, and/or the like . These computer program instructions can be loaded onto a general purpose computer, special purpose computer, or other programmable data processing equipment to form a machine, so that these instructions executed on a computer or other programmable data processing device can generate a device that implements a specified function. These computer program instructions can also be stored in a computer-readable memory, which can instruct the computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory can form a piece Manufactured products, including implementation devices that implement specified functions. Computer program instructions can also be loaded onto a computer or other programmable data processing device, so that a series of operating steps are performed on the computer or other programmable device to produce a computer-implemented process that allows the computer or other programmable device to execute Instructions can provide steps for implementing specified functions.
虽然在各种实施例中已经示出了本文的原理,但是许多特别适用于特定环境和操作要求的结构、布置、比例、元件、材料和部件的修改可以在不脱离本披露的原则和范围内使用。以上修改和其他改变或修正将被包含在本文的范围之内。Although the principles herein have been shown in various embodiments, many modifications of structures, arrangements, ratios, elements, materials, and components that are particularly suitable for specific environments and operating requirements can be made without departing from the principles and scope of this disclosure use. The above modifications and other changes or amendments will be included within the scope of this document.
前述具体说明已参照各种实施例进行了描述。然而,本领域技术人员将认识到,可以在不脱离本披露的范围的情况下进行各种修正和改变。因此,对于本披露的考虑将是说明性的而非限制性的意义上的,并且所有这些修改都将被包含在其范围内。同样,有关于各种实施例的优点、其他优点和问题的解决方案已如上所述。然而,益处、优点、问题的解决方案以及任何能产生这些的要素,或使其变得更明确的解决方案都不应被解释为关键的、必需的或必要的。本文中所用的术语“包括”和其任何其他变体,皆属于非排他性包含,这样包括要素列表的过程、方法、文章或设备不仅包括这些要素,还包括未明确列出的或不属于该过程、方法、系统、文章或设备的其他要素。此外,本文中所使用的术语“耦合”和其任何其他变体都是指物理连接、电连接、磁连接、光连接、通信连接、功能连接和/或任何其他连接。The foregoing specific description has been described with reference to various embodiments. However, those skilled in the art will recognize that various modifications and changes can be made without departing from the scope of the present disclosure. Therefore, consideration of this disclosure will be in an illustrative rather than a restrictive sense, and all such modifications will be included within its scope. Also, there have been the advantages, various advantages, and solutions to the problems of the various embodiments described above. However, benefits, advantages, solutions to problems, and any elements that can produce these, or solutions that make them more explicit, should not be interpreted as critical, necessary, or necessary. The term "comprising" and any other variants used in this article are non-exclusive, so that a process, method, article, or device that includes a list of elements includes not only these elements, but also those that are not explicitly listed or do not belong to the process , Methods, systems, articles or other elements of equipment. Furthermore, the term "coupled" and any other variations thereof used herein refer to physical connection, electrical connection, magnetic connection, optical connection, communication connection, functional connection, and/or any other connection.
具有本领域技术的人将认识到,在不脱离本发明的基本原理的情况下,可以对上述实施例的细节进行许多改变。因此,本发明的范围应根据以下权利要求确定。Those skilled in the art will recognize that many changes can be made to the details of the above-described embodiments without departing from the basic principles of the invention. Therefore, the scope of the present invention should be determined according to the following claims.

Claims (30)

  1. 一种血样分析方法,其特征在于,所述方法包括:A blood sample analysis method, characterized in that the method includes:
    对盛装在反应容器中的被测物进行光学检测,得到光学检测结果,所述被测物至少包含有被测血样的血浆;Performing optical detection on the test object contained in the reaction vessel to obtain an optical test result, where the test object contains at least plasma of the blood sample;
    根据所述光学检测结果得到反映被测物中干扰物情况的干扰物信息,所述干扰物是指对基于光学法的凝血检测项目的检测结果有影响的物质; Obtain interference information reflecting the condition of the interference in the object according to the optical detection result, where the interference refers to a substance that has an influence on the detection result of the coagulation detection item based on the optical method;
    根据所述干扰物信息确定对被测血样采用的凝血检测方法;Determine the coagulation detection method for the blood sample to be tested according to the interference information;
    当被测物中的干扰物不会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制光学法检测装置对被测物基于光学法进行凝血检测;When the interference in the test object does not affect the detection result of the coagulation detection item based on the optical method, the processor controls the optical method detection device to perform coagulation detection on the test object based on the optical method;
    当被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制磁珠法检测装置对被测物基于磁珠法进行凝血检测。When the interference in the test object will affect the detection result of the coagulation detection item based on the optical method, the processor controls the magnetic bead method detection device to perform the coagulation detection on the test object based on the magnetic bead method.
  2. 如权利要求1所述的方法,其特征在于,所述干扰物是指吸收特定波长光的物质,所述特定波长是指采用光学法对血浆和试剂的混合试样进行凝血检测时使用的光波长中的至少一种。The method according to claim 1, wherein the interfering substance refers to a substance that absorbs light of a specific wavelength, and the specific wavelength refers to light used for coagulation detection of a mixed sample of plasma and reagents by an optical method At least one of the wavelengths.
  3. 如权利要求2所述的方法,其特征在于,所述光学检测包括:The method of claim 2, wherein the optical detection comprises:
    采用至少一种波长的光对被测物进行照射;Use at least one wavelength of light to illuminate the measured object;
    检测所述被测物经光作用后的光学信息;Detecting the optical information of the test object after being subjected to light;
    根据所述光学信息得到所述被测物的光学检测结果。Obtain the optical detection result of the test object according to the optical information.
  4. 如权利要求3所述的方法,其特征在于,所述光学信息为光束通过所述被测物后的透射和/或散射光强。The method according to claim 3, wherein the optical information is transmission and/or scattered light intensity after the light beam passes through the object to be measured.
  5. 如权利要求3或4所述的方法,其特征在于还包括,根据所述光学信息计算所述被测物针对各特定波长光的吸光度值。The method according to claim 3 or 4, further comprising calculating the absorbance value of the test object for each specific wavelength of light based on the optical information.
  6. 如权利要求5所述的方法,其特征在于,当吸光度值大于预设阈值时,判断被测物中的干扰物会对基于光学法的凝血检测项目有影响。The method according to claim 5, wherein when the absorbance value is greater than a preset threshold, it is determined that the interference in the test object will affect the coagulation detection item based on the optical method.
  7. 如权利要求3所述的方法,其特征在于,采用至少一种特定波长的光对被测物进行照射。The method according to claim 3, wherein the object to be measured is irradiated with light of at least one specific wavelength.
  8. 如权利要求1所述的方法,其特征在于,所述光学检测包括:采集被测物的图像数据,得到光学检测结果。The method according to claim 1, wherein the optical detection comprises: collecting image data of the object to obtain an optical detection result.
  9. 如权利要求8所述的方法,其特征在于,根据所述图像数据得到颜色信息,根据所述颜色信息得到反映被测物中干扰物情况的干扰物信息。8. The method according to claim 8, wherein color information is obtained based on the image data, and interference information reflecting the condition of the interference in the object is obtained based on the color information.
  10. 如权利要求1-9任一所述的方法,其特征在于,对盛装在反应容器中的被测物进行光学检测中的被测物是血浆,或者是血浆和试剂的混合物,所述试剂包括稀释液、混合试剂和触发试剂中的至少一种。The method according to any one of claims 1-9, wherein the analyte in the optical detection of the analyte contained in the reaction vessel is plasma or a mixture of plasma and reagents, and the reagents include At least one of diluent, mixed reagent, and trigger reagent.
  11. 如权利要求1-9任一所述的方法,其特征在于,在为光学检测设置的专用位置、孵育区域、光学法检测区域或磁珠法检测区域对被测物进行所述光学检测。The method according to any one of claims 1 to 9, characterized in that the optical detection is performed on the test object in a dedicated position, an incubation area, an optical detection area, or a magnetic bead detection area provided for optical detection.
  12. 如权利要求1-9任一所述的方法,其特征在于,所述反应容器内部放置有磁珠,所述反应容器具有供磁珠在驱动力下进行移动的底部。The method according to any one of claims 1-9, wherein magnetic beads are placed inside the reaction vessel, and the reaction vessel has a bottom for the magnetic beads to move under driving force.
  13. 一种基于凝血分析仪的血样分析方法,其特征在于包括:A blood sample analysis method based on a blood coagulation analyzer, which includes:
    获取反映被测血样中干扰物情况的干扰物信息,所述干扰物是指对基于光学法的凝血检测有影响的物质;Obtain interference information that reflects the condition of interferences in the blood sample being tested. The interferences refer to substances that have an effect on the detection of blood coagulation based on optical methods;
    根据所述干扰物信息判断是基于光学法还是磁珠法对该被测血样进行凝血检测。According to the interference information, it is determined whether the blood sample to be tested is subjected to coagulation detection based on the optical method or the magnetic bead method.
  14. 如权利要求13所述的方法,其特征在于,根据所述干扰物信息判断是基于光学法还是磁珠法对该被测血样进行凝血检测包括:The method according to claim 13, wherein determining whether to perform coagulation detection on the blood sample to be tested based on the optical interference method or the magnetic bead method based on the interference information includes:
    当被测物中的干扰物不会对基于光学法的凝血检测有影响时,应用光学法检测装置对被测物进行凝血检测;When the interfering substance in the test object will not affect the coagulation detection based on the optical method, apply the optical method detection device to perform the coagulation detection on the test object;
    当被测物中的干扰物会对基于光学法的凝血检测有影响时,应用磁珠法检测装置对被测物进行凝血检测。When the interference in the test object will affect the coagulation detection based on the optical method, the magnetic bead method detection device is used to perform the coagulation detection on the test object.
  15. 如权利要求13所述的方法,其特征在于,所述干扰物是指吸收特定波长光的物质,所述特定波长是指采用光学法对血浆和试剂的混合试样进行凝血检测时使用的光波长中的至少一种。The method according to claim 13, wherein the interfering substance refers to a substance that absorbs light of a specific wavelength, and the specific wavelength refers to light used for coagulation detection of a mixed sample of plasma and reagents by an optical method At least one of the wavelengths.
  16. 如权利要求1至15中任一项所述的方法,其特征在于,基于光学法进行凝血检测的光学法检测区域和基于磁珠法进行凝血检测的磁珠法检测区域是同一检测区域。The method according to any one of claims 1 to 15, wherein the optical method detection area for performing coagulation detection based on the optical method and the magnetic bead method detection area for performing coagulation detection based on the magnetic bead method are the same detection area.
  17. 如权利要求1至15中任一项所述的方法,其特征在于还包括:输出确定采用光学法或磁珠法的提示信息。The method according to any one of claims 1 to 15, further comprising: outputting prompt information for determining whether to use an optical method or a magnetic bead method.
  18. 一种凝血分析仪,其特征在于包括预判装置、光学法检测装置、磁珠法检测装置、被测物转运机构和处理器;A blood coagulation analyzer, characterized in that it includes a pre-judgment device, an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
    所述预判装置用于在处理器的控制下对被测物在其进行凝血检测之前先进行光学检测,得到光学检测结果,所述被测物至少包含有被测血样的血浆;The pre-judgment device is used for performing optical detection on the test object before performing the blood coagulation test under the control of the processor to obtain an optical detection result, where the test object includes at least plasma of the blood sample;
    所述光学法检测装置用于在处理器的控制下对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号;The optical method detection device is used for performing coagulation detection on the measured object based on the optical method under the control of the processor, and outputs an electrical signal reflecting the coagulation situation;
    所述磁珠法检测装置用于在处理器的控制下对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号;The magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
    所述被测物转运机构用于在处理器的控制下将容纳有被测物的反应容器转运到预设的位置;The test object transfer mechanism is used to transfer the reaction container containing the test object to a preset position under the control of the processor;
    所述处理器用于根据所述光学检测结果确定由光学法检测装置对被测物进行凝血检测还是磁珠法检测装置对被测物进行凝血检测,并接收反映凝固情况的电信号,处理后得到被测血样的测量参数。The processor is used to determine whether the optical method detection device performs coagulation detection on the analyte or the magnetic bead method detection device performs coagulation detection on the analyte according to the optical detection result, and receives an electrical signal reflecting the coagulation condition, which is obtained after processing Measurement parameters of the blood sample being tested.
  19. 如权利要求18所述的凝血分析仪,其特征在于,所述处理器用于根据光学检测结果得到反映被测物中干扰物情况的干扰物信息,所述干扰物是指对基于光学法的凝血检测项目的检测结果有影响的物质;当被测物中的干扰物不会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制光学法检测装置对被测物进行凝血检测;当被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响时,处理器控制磁珠法检测装置对被测物进行凝血检测。The coagulation analyzer according to claim 18, characterized in that the processor is used to obtain the interference information reflecting the condition of the interference in the test object according to the optical detection result, and the interference refers to the coagulation based on the optical method Substances that have an influence on the test result of the test item; when the interference in the test object does not affect the test result of the coagulation test item based on the optical method, the processor controls the optical method detection device to perform coagulation test on the test object; When the interference in the test object will affect the detection result of the coagulation test item based on the optical method, the processor controls the magnetic bead method detection device to perform the coagulation test on the test object.
  20. 如权利要求19所述的凝血分析仪,其特征在于,所述干扰物是指吸收特定波长光的物质,所述特定波长是指采用光学法对血浆和试剂的混合试样进行凝血检测时使用的光波长中的至少一种。The coagulation analyzer according to claim 19, wherein the interfering substance refers to a substance that absorbs light of a specific wavelength, and the specific wavelength refers to an optical method used to perform coagulation detection on a mixed sample of plasma and reagent At least one of the wavelengths of light.
  21. 如权利要求20所述的凝血分析仪,其特征在于,所述预判装置包括光电检测装置,所述光电检测装置包括光发射端和光接收端,所述光发射端用于采用至少一种特定波长光或波长与特定波长接近的光对被测物进行照射,光接收端用于检测所述被测物经光作用后的光学信息,得到所述被测物针对各特定波长光的光学检测结果。The coagulation analyzer according to claim 20, wherein the pre-judgment device includes a photoelectric detection device, and the photoelectric detection device includes a light emitting end and a light receiving end, and the light emitting end is used to adopt at least one specific Wavelength light or light with a wavelength close to a specific wavelength irradiates the test object, and the light receiving end is used to detect the optical information of the test object after being subjected to light to obtain optical detection of the test object for each specific wavelength of light result.
  22. 如权利要求21所述的凝血分析仪,其特征在于,所述光学信息为光束通过所述被测物后的透射和/或散射光强。The coagulation analyzer according to claim 21, wherein the optical information is transmitted and/or scattered light intensity after the light beam passes through the object to be measured.
  23. 如权利要求21或22所述的凝血分析仪,其特征在于,所述处理器根据所述光学信息计算所述被测物针对各特定波长光的吸光度值,在至少有一种特定波长光的吸光度值大于预设阈值时,判断被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响。The coagulation analyzer according to claim 21 or 22, wherein the processor calculates the absorbance value of the test object for each specific wavelength of light based on the optical information, and absorbance of at least one specific wavelength of light When the value is greater than the preset threshold, it is judged that the interference in the test object will affect the detection result of the coagulation detection item based on the optical method.
  24. 如权利要求18所述的凝血分析仪,其特征在于,所述预判装置包括图像采集装置,所述图像采集装置用于采集被测物的图像数据,得到光学检测结果;所述处理器根据所述图像数据识别被测物的颜色,将被测物的颜色和预设颜色比较,在被测物的颜色和预设颜色相同或相近时,判断被测物中的干扰物会对基于光学法的凝血检测项目的检测结果有影响。The coagulation analyzer according to claim 18, wherein the pre-judgment device includes an image acquisition device, and the image acquisition device is used to collect image data of the object to be measured to obtain an optical detection result; The image data identifies the color of the test object, compares the color of the test object with the preset color, and when the color of the test object is the same as or close to the preset color, it is determined that the interfering object in the test object will be based on the optical The test result of the coagulation test item of the method has an influence.
  25. 如权利要求18所述的凝血分析仪,其特征在于,所述预判装置对被测物进行光学检测中的被测物是血浆,或者是血浆和试剂的混合物,所述试剂包括稀释液、混合试剂和触发试剂中的至少一种。The coagulation analyzer according to claim 18, wherein the pre-judgment device performs plasma detection on the test object, and the test object is plasma or a mixture of plasma and reagents, and the reagents include diluent, At least one of a mixed reagent and a trigger reagent.
  26. 如权利要求18所述的凝血分析仪,其特征在于,所述预判装置对被测物进行光学检测的位置是专用位置、孵育区域、光学法检测区域或磁珠法检测区域。The coagulation analyzer according to claim 18, wherein the position where the pre-judgment device performs optical detection on the object is a dedicated position, an incubation area, an optical detection area, or a magnetic bead detection area.
  27. 一种凝血分析仪,其特征在于包括光学法检测装置、磁珠法检测装置、被测物转运机构和处理器;A blood coagulation analyzer, which is characterized by including an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
    所述光学法检测装置用于在处理器的控制下对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号;The optical method detection device is used for performing coagulation detection on the measured object based on the optical method under the control of the processor, and outputs an electrical signal reflecting the coagulation situation;
    所述磁珠法检测装置用于在处理器的控制下对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号;The magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation;
    所述被测物转运机构用于在处理器的控制下将容纳有被测物的反应容器转运到预设的位置;The test object transfer mechanism is used to transfer the reaction container containing the test object to a preset position under the control of the processor;
    所述处理器用于获取反映被测血样中干扰物情况的干扰物信息,根据所述干扰物信息判断是由光学法检测装置对被测物进行凝血检测还是磁珠法检测装置对被测物进行凝血检测,并接收反映凝固情况的电信号,处理后得到被测血样的测量参数,所述干扰物是指对基于光学法的凝血检测有影响的物质。The processor is used to obtain the interference information reflecting the condition of the interference in the blood sample to be tested, and determine whether the optical method detection device performs coagulation detection on the test object or the magnetic bead method detection device on the test object according to the interference information Coagulation detection, and receiving electrical signals reflecting the coagulation situation, after processing, the measurement parameters of the blood sample to be measured are obtained, and the interfering substance refers to a substance that has an influence on the coagulation detection based on the optical method.
  28. 如权利要求18或27所述的凝血分析仪,其特征在于,基于光学法进行凝血检测的光学法检测区域和基于磁珠法进行凝血检测的磁珠法检测区域是同一检测区域。The coagulation analyzer according to claim 18 or 27, wherein the optical method detection area for performing coagulation detection based on the optical method and the magnetic bead method detection area for performing coagulation detection based on the magnetic bead method are the same detection area.
  29. 一种凝血分析仪,其特征在于包括光学法检测装置、磁珠法检测装置、被测物转运机构和处理器;A blood coagulation analyzer, which is characterized by including an optical method detection device, a magnetic bead method detection device, an object transport mechanism and a processor;
    所述光学法检测装置用于在处理器的控制下对被测物基于光学法进行凝血检测,输出反映凝固情况的电信号;The optical method detection device is used for performing coagulation detection on the measured object based on the optical method under the control of the processor, and outputs an electrical signal reflecting the coagulation situation;
    所述磁珠法检测装置用于在处理器的控制下对被测物基于磁珠法进行凝血检测,输出反映凝固情况的电信号;所述磁珠法检测装置的检测区域和光学法检测装置的检测区域是同一检测区域;The magnetic bead method detection device is used to perform coagulation detection on the measured object based on the magnetic bead method under the control of the processor, and output an electrical signal reflecting the coagulation situation; the detection area and the optical method detection device of the magnetic bead method detection device The detection area is the same detection area;
    所述被测物转运机构用于在处理器的控制下将容纳有被测物的反应容器转运到所述共用检测区域;The test object transfer mechanism is used to transfer the reaction container containing the test object to the common detection area under the control of the processor;
    所述处理器用于控制先由光学法检测装置对被测物进行凝血检测,在光学法检测装置检测不准确或不能输出反映凝固情况的电信号时,再由磁珠法检测装置对被测物进行凝血检测。The processor is used to control the coagulation detection of the test object by the optical method detection device. When the optical method detection device detects inaccuracy or fails to output an electrical signal reflecting the coagulation condition, the magnetic bead method detection device performs the test on the test object Perform a blood clotting test.
  30. 一种计算机可读存储介质,其特征在于,包括程序,所述程序能够被处理器执行以实现如权利要求1-17中任一项所述的方法。A computer-readable storage medium, characterized by comprising a program, which can be executed by a processor to implement the method according to any one of claims 1-17.
PCT/CN2018/123800 2018-12-26 2018-12-26 Blood sample analysis method and blood coagulation analyzer WO2020132926A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201880099356.1A CN112955742A (en) 2018-12-26 2018-12-26 Blood sample analysis method and blood coagulation analyzer
PCT/CN2018/123800 WO2020132926A1 (en) 2018-12-26 2018-12-26 Blood sample analysis method and blood coagulation analyzer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/123800 WO2020132926A1 (en) 2018-12-26 2018-12-26 Blood sample analysis method and blood coagulation analyzer

Publications (1)

Publication Number Publication Date
WO2020132926A1 true WO2020132926A1 (en) 2020-07-02

Family

ID=71126852

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/123800 WO2020132926A1 (en) 2018-12-26 2018-12-26 Blood sample analysis method and blood coagulation analyzer

Country Status (2)

Country Link
CN (1) CN112955742A (en)
WO (1) WO2020132926A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114577743A (en) * 2022-05-05 2022-06-03 深圳市帝迈生物技术有限公司 Method and device for determining interferent in sample, equipment and storage medium
CN114813590A (en) * 2022-06-30 2022-07-29 深圳市帝迈生物技术有限公司 Sample detection method, sample analyzer and control device thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109613285A (en) * 2018-12-12 2019-04-12 广东普门生物医疗科技有限公司 Biochemical immunity one analyzer and method of sample analysis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1162457A2 (en) * 2000-06-09 2001-12-12 GOLDSTEIN, Sheldon Multiple coagulation test system and method of using a multiple coagulation test system
WO2010051362A1 (en) * 2008-10-29 2010-05-06 T2 Biosystems, Inc. Nmr detection of coagulation time
CN101806806A (en) * 2009-02-17 2010-08-18 希森美康株式会社 Sample analyzer, sample analyzing method and computer system
CN107315094A (en) * 2017-07-27 2017-11-03 深圳传世生物医疗有限公司 Blood coagulation analyzer and blood coagulation analyzing method
CN108535503A (en) * 2018-07-12 2018-09-14 成都艾科斯伦医疗科技有限公司 Automatic coagulation analyzer and its application method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4986487B2 (en) * 2006-03-30 2012-07-25 シスメックス株式会社 Blood clotting time measurement device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1162457A2 (en) * 2000-06-09 2001-12-12 GOLDSTEIN, Sheldon Multiple coagulation test system and method of using a multiple coagulation test system
WO2010051362A1 (en) * 2008-10-29 2010-05-06 T2 Biosystems, Inc. Nmr detection of coagulation time
CN101806806A (en) * 2009-02-17 2010-08-18 希森美康株式会社 Sample analyzer, sample analyzing method and computer system
CN107315094A (en) * 2017-07-27 2017-11-03 深圳传世生物医疗有限公司 Blood coagulation analyzer and blood coagulation analyzing method
CN108535503A (en) * 2018-07-12 2018-09-14 成都艾科斯伦医疗科技有限公司 Automatic coagulation analyzer and its application method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114577743A (en) * 2022-05-05 2022-06-03 深圳市帝迈生物技术有限公司 Method and device for determining interferent in sample, equipment and storage medium
CN114813590A (en) * 2022-06-30 2022-07-29 深圳市帝迈生物技术有限公司 Sample detection method, sample analyzer and control device thereof

Also Published As

Publication number Publication date
CN112955742A (en) 2021-06-11

Similar Documents

Publication Publication Date Title
US11022558B2 (en) Coagulation analyzer and coagulation analysis method
JP5164388B2 (en) Sample measuring device
EP3076173B1 (en) Method for blood sample determination and blood sample analyzer
JP5955934B2 (en) Blood coagulation analyzer
JP7002718B2 (en) Blood sample analysis method, analyzer and computer program
US20140255254A1 (en) Blood coagulation analyzer
JP4999679B2 (en) Sample analyzer
WO2020132926A1 (en) Blood sample analysis method and blood coagulation analyzer
CN101151521A (en) Method of analyte analysis and analyte analyzer
JP2019086517A (en) Blood coagulability evaluation method
JP2016527485A (en) Calibration method for photometry
CN104471381A (en) Automatic analysis device, and automatic analysis method
JP2019086518A (en) Blood coagulability assessment method
JP5312834B2 (en) Blood coagulation analyzer, blood coagulation analysis method, and computer program
JP2016191677A (en) Specimen analyzer, blood coagulation analyzer, specimen analysis method and computer program
CN207636616U (en) Blood coagulation analyzer
JP2014137319A (en) Automatic analyzer
JP6667380B2 (en) Method for blood analysis, blood analyzer, computer program, calibrator set, and method for producing calibrator set
CN111272678A (en) Sample detection method, blood coagulation analyzer and storage medium
JP7241209B2 (en) Blood Coagulation Measuring Device, Method for Measuring Blood Coagulation Time, Method for Determining Completion of Blood Coagulation Reaction, and Automated Blood Centrifuge
WO2021207898A1 (en) Sample analysis device and method
CN204269656U (en) A kind of test macro and immuno-chromatographic test paper strip thereof
JPS58172537A (en) Apparatus for measuring light scattering
CN115244382A (en) Sample analysis method and device
CN115244403A (en) Sample analysis device and method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18945331

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 17/08/2021)

122 Ep: pct application non-entry in european phase

Ref document number: 18945331

Country of ref document: EP

Kind code of ref document: A1